{"gene":"ARF6","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1995,"finding":"ARF6 localizes to the endosomal/plasma membrane system (not the Golgi) and does not affect COP1 or γ-adaptin assembly on Golgi membranes. GTP hydrolysis-defective ARF6 localizes to the plasma membrane and induces extensive plasma membrane invaginations with depletion of endosomes; GTP-binding-defective ARF6 localizes exclusively to endosomal structures and causes accumulation of coated endocytic structures.","method":"Transient transfection of epitope-tagged ARF6 wild-type and GTPase mutants; immuno-electron microscopy; immunofluorescence","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization by immuno-EM with multiple mutants, replicated across the field as foundational work","pmids":["7896867"],"is_preprint":false},{"year":2001,"finding":"ARF6 activates phosphatidylinositol 4-phosphate 5-kinase (PIP5K) to generate PIP2 at the plasma membrane and on tubular endosomal structures. PIP2 turnover controlled by the ARF6 GTP/GDP cycle is critical for membrane recycling through the ARF6 plasma membrane-endosomal pathway; constitutively active ARF6-Q67L traps PM proteins (β1-integrin, plakoglobin, MHCI) in PIP2-positive, actin-coated vacuoles unable to recycle.","method":"GFP-PH domain reporter for PIP2 localization; expression of ARF6 mutants and EFA6 exchange factor; fluorescence microscopy","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (PIP2 reporter, mutants, exchange factor overexpression), replicated by subsequent studies","pmids":["11535619"],"is_preprint":false},{"year":2001,"finding":"ARF6 associates with phospholipase D1 and PKCα upon Fcγ RI immune-complex aggregation; PLD1 lies upstream of all Fcγ RI-mediated PKC activity (PKCδ, ε, ζ translocation requires PLD1, not PKCα activity per se). ARF6 and PKCα form a complex with PLD1 to couple Fcγ RI to PLD1 activation.","method":"Co-immunoprecipitation; antisense oligonucleotide knockdown of PLD1; butan-1-ol phosphatidic acid assay; PKC translocation assays","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and functional knockdown in same study, single lab","pmids":["11516649"],"is_preprint":false},{"year":2002,"finding":"ARF6 redistributes to the cleavage furrow during telophase; ARF6-GTP levels transiently increase as cells progress through cytokinesis (measured by pull-down assay). Constitutively active ARF6 localizes to the plasma membrane at the cleavage furrow; dominant negative ARF6 remains cytoplasmic.","method":"Endogenous ARF6 immunofluorescence during mitosis; novel ARF6-GTP pull-down assay; expression of GTPase mutants","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment plus biochemical GTP-loading assay, single lab","pmids":["12016212"],"is_preprint":false},{"year":2003,"finding":"ARF6 inactivation and acquisition of PI3P are required for convergence of non-clathrin endosomes with EEA1-positive early endosomes. Constitutively active ARF6-Q67L causes MHCI and Tac to accumulate in enlarged PIP2-enriched vacuoles and blocks their fusion with clathrin-cargo-containing endosomes and subsequent degradation, without affecting clathrin-cargo trafficking.","method":"Expression of ARF6 mutants; PI3-kinase inhibitor (wortmannin/LY294002); immunofluorescence; live-cell imaging","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (mutant) and pharmacological perturbation with defined cargo readout, single lab","pmids":["12589044"],"is_preprint":false},{"year":2003,"finding":"ARF6 regulates axonal elongation and branching through downstream activation of PI(4)P 5-kinase α. Catalytically inactive ARNO or dominant-negative ARF6 enhances axonal extension/branching; this effect is abrogated by constitutively active ARF6. PI(4)P 5-kinase α acts downstream of ARF6 in this pathway. ARF6 inactivation depletes Mena from growth cone leading edges.","method":"Expression of ARNO and ARF6 dominant mutants in cultured rat hippocampal neurons; genetic epistasis by co-expression; immunofluorescence for Mena","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis experiment with multiple mutants plus downstream effector rescue, single lab","pmids":["14565977"],"is_preprint":false},{"year":2003,"finding":"ARF6 regulates PIP2 formation at the phagocytic cup and activates PIP5K during β1-integrin-mediated bacterial (Yersinia) uptake. ARF6 defective for nucleotide binding reduces PIP2 around bound bacteria and impairs uptake. Overproduction of ARF6 or PIP5K can bypass the Rac1-GTP requirement for bacterial entry.","method":"Membrane-targeted PIP2 phosphatase expression; ARF6 dominant-negative mutant; PIP5K overexpression; Rac1 inactivation by YopE; bacterial invasion assay","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple mutants plus functional phagocytosis readout, single lab","pmids":["12925676"],"is_preprint":false},{"year":2003,"finding":"An initial ARF6-dependent decrease in Rac1-GTP is necessary for epithelial cell-cell dissociation during cell scattering; this is followed by coordinated increases in both ARF6 and Rac1 activation during cell migration.","method":"Active GTPase pull-down assays for endogenous ARF6-GTP and Rac1-GTP during sequential stages of HGF/scatter factor-induced MDCK cell scattering","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical pull-down of endogenous active GTPases at defined cellular stages, single lab","pmids":["12609992"],"is_preprint":false},{"year":2000,"finding":"ACAP1 and ACAP2 are ARF6-specific GTPase-activating proteins (GAPs) that function in the cell periphery. In vitro, ACAP1 and ACAP2 have phosphoinositide-dependent GAP activity preferring ARF6 over ARF1 and ARF5. In cells, overexpression of ACAP1/2 blocks ARF6-dependent membrane protrusions; ACAP1/2 are recruited to peripheral tubular membranes where ARF6 activates for membrane recycling.","method":"In vitro GAP assay with purified proteins; ARF6-GTP competition; dominant mutant cell biology; immunofluorescence co-localization","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro GAP assay with substrate specificity plus cell-based functional readout, replicated across multiple subsequent studies","pmids":["11062263"],"is_preprint":false},{"year":2004,"finding":"ARF6 localizes to invadopodia of breast cancer cells; siRNA-mediated suppression of ARF6 blocks invadopodia formation, localized matrix degradation, and Matrigel transmigration but not cell adhesion. Both GTP hydrolysis-defective (Q67L) and GTP-binding-defective (T27N) ARF6 mutants block invasion, demonstrating that continuous ARF6 GTPase cycling is required.","method":"siRNA knockdown; expression of GTPase mutants; invasion assays (Matrigel transmigration, matrix degradation); immunofluorescence","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA KD plus dominant mutant analysis with specific phenotypic readouts, replicated by independent labs","pmids":["15087504"],"is_preprint":false},{"year":2005,"finding":"ARF6 is required for completion of cytokinesis. siRNA depletion of ARF6 disrupts the final stages of cytokinesis. Ku70, a DNA-binding protein, is identified as a new ARF6-interacting protein that forms a complex with ARF6 preferentially during mitosis.","method":"siRNA knockdown; co-immunoprecipitation; immunofluorescence during cell division","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with specific cytokinesis phenotype plus Co-IP for Ku70 interaction, single lab","pmids":["16181626"],"is_preprint":false},{"year":2005,"finding":"ARF6 N-terminal α-helix is co-translationally myristoylated; both the helix and myristate affect nucleotide exchange, membrane association, and interaction with effector proteins.","method":"In vitro myristoylation; preparation and biochemical characterization of myristoylated Arf6","journal":"Methods in enzymology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical characterization, single lab, no mutagenesis validation in cells","pmids":["16413267"],"is_preprint":false},{"year":2006,"finding":"V-ATPase a2-isoform on early endosomes interacts with ARNO in an intra-endosomal acidification-dependent manner; ARF6 interacts with the c-subunit of V-ATPase. Disruption of ARNO–V-ATPase interaction reversibly inhibits endocytosis and blocks protein trafficking from early to late endosomal compartments.","method":"Co-immunoprecipitation; pharmacological inhibition of endosomal acidification (bafilomycin); dominant-negative constructs; endocytosis assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP plus pharmacological and genetic perturbation with functional endocytic readout, published in high-impact journal","pmids":["16415858"],"is_preprint":false},{"year":2006,"finding":"BRAG2 (GEP100/Arf-GEP100) is a GEF that activates ARF6 in vivo. siRNA depletion of BRAG2 causes accumulation of β1-integrin on the cell surface and enhanced cell attachment/spreading on fibronectin. Conversely, siRNA depletion of ARF6 causes intracellular accumulation of β1-integrin and reduced adhesion, demonstrating that ARF6 regulates both endocytosis and recycling of β1-integrins.","method":"siRNA knockdown of BRAG2 and ARF6; β1-integrin surface and intracellular localization by immunofluorescence and flow cytometry; cell adhesion assay","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA of both GEF and GTPase with reciprocal cargo phenotypes, clear mechanistic dissection","pmids":["16461286"],"is_preprint":false},{"year":2006,"finding":"ARF6 and EFA6A regulate dendritic spine development and maintenance. Active ARF6 promotes spine formation from filopodia; EFA6A promotes spine formation in an ARF6 activation-dependent manner. siRNA knockdown of ARF6 or EFA6A decreases spine formation and reduces filopodia-to-spine conversion. ARF6 and EFA6A protect mature spines from inactivity-induced destabilization.","method":"siRNA knockdown; expression of dominant mutants; live-cell imaging; morphometric analysis of spine/filopodia ratio","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD plus dominant mutants plus live imaging, single lab","pmids":["16672654"],"is_preprint":false},{"year":2006,"finding":"A kinase-deficient TrkCT1 receptor binds scaffold protein tamalin in a ligand (NT3)-dependent manner; this complex activates ARF6 which in turn activates Rac1. NT3 triggers ARF6 membrane translocation, causing membrane ruffling and cellular protrusions. This identifies NT3 as an upstream regulator of ARF6.","method":"Co-immunoprecipitation; ARF6 membrane translocation imaging; dominant-negative mutants; Rac1 GTP pull-down","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional readout of ARF6 and Rac1 activation downstream of receptor, single lab","pmids":["16636148"],"is_preprint":false},{"year":2006,"finding":"ACAP4 is a novel ARF6-specific GAP with phosphatidylinositol 4,5-bisphosphate-dependent GAP activity. ACAP4 colocalizes with ARF6 at membrane ruffles upon EGF stimulation. Depletion of ACAP4 by siRNA or inhibition of ARF6 GTP hydrolysis suppresses ARF6-dependent cell migration in wound healing assays.","method":"Proteomic identification; in vitro GAP activity assay with PIP2 dependence; siRNA knockdown; co-localization; wound-healing migration assay","journal":"Molecular & cellular proteomics : MCP","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro GAP assay plus cell-based siRNA knockdown with migration phenotype, multiple methods in single study","pmids":["16737952"],"is_preprint":false},{"year":2006,"finding":"ARF6 activity is regulated during FcγR-mediated phagocytosis. ARF6 activation is restricted to the leading edge of the phagocytic cup. A PI3-kinase-dependent signal transition controls the sequential activation of ARF6 (early, cup leading edge) and ARF1 (delayed, over phagosome). PI3-K inhibition causes persistent ARF6 activation and minimal ARF1 activation.","method":"FRET stoichiometric microscopy of CFP/YFP-ARF chimeras and GTP-ARF binding domain; PI3-kinase pharmacological inhibition; phagocytosis assay","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative FRET-based GTPase activation imaging in living cells with spatial-temporal resolution, multiple orthogonal controls","pmids":["16669702"],"is_preprint":false},{"year":2006,"finding":"Dominant active ARF6 selectively activates PLD2 (not PLD1) in vivo. Dominant negative ARF6 selectively inhibits PLD2. ARF6 activates PLD2 in a cholesterol-dependent membrane microdomain. Co-localization of ARF6 and PLD isoforms was demonstrated at the cell periphery.","method":"Co-expression of ARF6 mutants with PLD1/PLD2 in HeLa cells; cell fractionation; methyl-β-cyclodextrin cholesterol depletion; PLD activity assay","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional cell-based assay with multiple mutants plus cholesterol depletion, single lab","pmids":["15759270"],"is_preprint":false},{"year":2006,"finding":"TSHR (thyrotropin receptor) recycling relies on an hScrib-βPIX-GIT1-ARF6 pathway. ARF6 is activated during TSH stimulation of thyroid cells and is required for TSHR recycling. hScrib directly binds TSHR and associates with a βPIX-GIT1 complex; GIT1 (an ARF6 GAP) and ARF6 are both required for receptor recycling.","method":"Dominant-negative constructs; siRNA knockdown; TSHR recycling assay; ARF6 activation assay; co-immunoprecipitation","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA plus dominant-negative with functional GPCR trafficking readout, pathway placed by multiple genetic perturbations, single lab","pmids":["15775968"],"is_preprint":false},{"year":2007,"finding":"ARF6 regulates angiotensin II type 1 receptor (AT1R) endocytosis by controlling recruitment of AP-2 and clathrin. ARF6-GDP binds β2-adaptin directly; ARF6-GTP preferentially binds clathrin heavy chain. ARF6 depletion prevents agonist-dependent recruitment of β2-adaptin and clathrin to activated AT1R and impairs β-arrestin 2 clustering.","method":"In vitro binding assays; co-immunoprecipitation; GFP-tagged adaptors; siRNA knockdown; AT1R endocytosis assay","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro direct binding assays plus cell-based functional validation, single lab","pmids":["17719203"],"is_preprint":false},{"year":2007,"finding":"ARF6 activation downstream of Gαq: Gαq forms molecular complexes preferentially with activated ARNO and ARF6. Direct binding between purified Gαq and ARNO was demonstrated. Gαq-dependent TPβ receptor stimulation activates ARF6, leading to PIP2 production and TPβ receptor internalization.","method":"Co-immunoprecipitation; purified protein binding assay; ARF6 activation assay; PIP2 production assay; receptor internalization assay","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct binding with purified proteins plus cell-based functional assays, single lab","pmids":["16650966"],"is_preprint":false},{"year":2007,"finding":"GULP (CED-6) is a positive regulator of ARF6. GULP binds GDP-bound ARF6 directly via its PTB domain, associates with the ARF6-GAP ACAP1, reverses ACAP1-mediated decrease in ARF6-GTP, and forms a tripartite GULP-ACAP1-ARF6-GDP complex that sequesters ACAP1, thereby increasing cellular ARF6-GTP levels.","method":"Co-immunoprecipitation of endogenous proteins; direct pulldown; siRNA knockdown; ARF6-GTP pull-down; cell migration assay","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple binding assays (Co-IP, direct pulldown, tripartite complex) plus functional readout, single lab","pmids":["17398097"],"is_preprint":false},{"year":2007,"finding":"ARF6-dependent tubulogenesis requires activation of ERK and subsequent Rac1 activation via ERK-induced upregulation of the urokinase plasminogen activator receptor (uPAR). ARF6 activation is necessary and sufficient to initiate tubule extension in 3D MDCK cultures and regulates subcellular distribution of Rac1 to tubule extensions.","method":"Inducible expression of ARF6 mutants; 3D cell culture (Matrigel); ERK activation assays; Rac1 distribution imaging","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible mutant expression plus mechanistic downstream pathway dissection in 3D culture model, single lab","pmids":["17363898"],"is_preprint":false},{"year":2007,"finding":"Fbx8, an F-box protein containing a Sec7 domain, mediates ubiquitination of ARF6. This ubiquitination is not linked to immediate proteasomal degradation but renders ARF6 functionally inactive; Fbx8 knockdown causes ARF6 hyperactivation. Both F-box and Sec7 domains of Fbx8 are required to suppress ARF6 activity and tumor cell invasiveness.","method":"Co-immunoprecipitation; ubiquitination assay; siRNA knockdown; ARF6 activity assay; invasion assay; domain deletion mutants","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination assay plus siRNA KD plus domain mutagenesis, single lab","pmids":["18094045"],"is_preprint":false},{"year":2007,"finding":"CaSR (calcium-sensing receptor) stimulation induces plasma membrane ruffling via a β-arrestin-1/ARNO/ARF6/ELMO cascade. β-arrestin-1 co-immunoprecipitates with CaSR and ARNO; agonist treatment triggers co-translocation of CaSR, β-arrestin-1 and ARNO to membrane protrusions. ARF6 and ELMO are required for CaSR-dependent cytoskeletal reorganization.","method":"Co-immunoprecipitation; dominant-negative constructs; siRNA knockdown; immunofluorescence co-localization at membrane ruffles","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus siRNA/dominant-negative with morphological readout, single lab","pmids":["17623778"],"is_preprint":false},{"year":2008,"finding":"ARF6 is required for dendritic cell podosome formation and migration. Expression of either Q67L (GTP-locked) or T44N (GDP-locked) ARF6 mutants strongly inhibits F-actin-rich podosome formation and impairs immature DC migration toward CCL3. LPS-stimulated macropinocytosis is suppressed by Q67L ARF6.","method":"Retroviral expression of ARF6 mutants in primary murine dendritic cells; F-actin podosome quantification; migration assay toward chemokines","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — both GDP- and GTP-locked mutants in primary cells with specific phenotypic readouts, single lab","pmids":["18286566"],"is_preprint":false},{"year":2009,"finding":"ARF6 GTP/GDP cycle regulates the release of protease-loaded plasma membrane-derived microvesicles from tumor cells. Mechanistically: ARF6-GTP activates phospholipase D, which recruits ERK to the plasma membrane; ERK phosphorylates and activates MLCK; MLCK-mediated MLC phosphorylation is required for microvesicle release. PKC-mediated MLC phosphorylation (downstream of ARF6 inhibition) blocks shedding.","method":"ARF6 mutant expression; PLD inhibition; ERK inhibition; MLCK inhibition; MLC phosphorylation assay; microvesicle quantification","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — linear pathway established by multiple inhibitors and mutants with quantitative vesicle shedding readout, replicated in the field","pmids":["19896381"],"is_preprint":false},{"year":2009,"finding":"EGFR activates ARF6 through the GEF GEP100 in breast cancer cells to promote invasion and metastasis via the EGFR-GEP100-ARF6-AMAP1 pathway. GEP100 directly binds ligand-activated EGFR. Both ARF6 and AMAP1 must be highly overexpressed and EGFR must be ligand-activated for full invasion pathway activation.","method":"Co-immunoprecipitation of GEP100 with EGFR; siRNA knockdowns; ARF6 activity assay; Matrigel invasion assay","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus multiple siRNA knockdowns with invasion readout, single lab","pmids":["19416474"],"is_preprint":false},{"year":2009,"finding":"EphA2, upon ligand activation by ephrin-A, suppresses ARF6 activity through a Nck1-Git1 signaling pathway. Ligand-activated EphA2 via phospho-Tyr594 binds Nck1 SH2 domain; Nck1 SH3 domain binds Git1 synaptic localizing domain; Git1 then suppresses ARF6. This suppression promotes cell compaction and polarization, enhancing E-cadherin-based cell-cell contacts.","method":"ARF6 activity assay; co-immunoprecipitation; phospho-tyrosine mutant EphA2; domain-specific mutants; cell compaction/polarity assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mutant dissection plus ARF6 activity assay with morphological phenotype, single lab","pmids":["19193766"],"is_preprint":false},{"year":2010,"finding":"TBC1D24 binds ARF6 (co-immunoprecipitation). TBC1D24 overexpression increases neurite length and arborization; FIME disease mutations (D147H, A509V) significantly revert this phenotype, implicating the ARF6-dependent pathway in brain hyperexcitability.","method":"Co-immunoprecipitation; TBC1D24 overexpression and disease mutant expression; neurite morphometry in neurons","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single Co-IP plus functional overexpression assay, mechanistic link to ARF6 pathway established but signaling detail not fully resolved","pmids":["20727515"],"is_preprint":false},{"year":2010,"finding":"Activated H-Ras induces methuosis via downstream activation of Rac1 combined with reciprocal inactivation of ARF6. Rac1 activation by H-Ras(G12V) decreases ARF6-GTP; this is mediated by Rac1 stimulation of the ARF6-GAP GIT1. Constitutively active Rac1 interacts with GIT1 by co-immunoprecipitation; shRNA ablation of GIT1 prevents ARF6 inactivation and vacuolization.","method":"ARF6-GTP and Rac1-GTP pull-down assays; shRNA knockdown of GIT1; Rac1 inhibitor EHT 1864; co-immunoprecipitation; vacuolization scoring","journal":"Molecular cancer research : MCR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic and pharmacological perturbations with biochemical and cellular readouts, single lab","pmids":["20713492"],"is_preprint":false},{"year":2011,"finding":"GEP100/Brag2 mediates Sema3E-induced ARF6 activation in endothelial cells downstream of Plexin-D1. Upon Sema3E activation, Plexin-D1 recruits PI4P5-kinase; its product PI(4,5)P2 binds the PH domain of GEP100, enhancing its GEF activity toward ARF6, leading to disassembly of integrin-mediated focal adhesions.","method":"Co-immunoprecipitation of Plexin-D1 with PIP5K; PH domain PIP2-binding assay; ARF6 activity assay; focal adhesion disassembly imaging; dominant-negative GEP100","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical PH domain binding assay plus ARF6 activity and functional focal adhesion readout, single lab","pmids":["21795701"],"is_preprint":false},{"year":2011,"finding":"VEGFR2 recruits GEP100 to activate ARF6, and the GEP100-ARF6-AMAP1-cortactin pathway is essential for VEGF-induced angiogenesis activities (cell migration, tube formation, permeability enhancement, VE-cadherin endocytosis).","method":"Co-immunoprecipitation; siRNA knockdowns; ARF6 activity assay; tube formation and migration assays; VE-cadherin endocytosis assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus multiple siRNA knockdowns with multiple functional readouts, single lab","pmids":["21858086"],"is_preprint":false},{"year":2011,"finding":"ARF6 negatively regulates Rab35 activation by using EPI64B as an effector. EPI64B is a Rab35-GAP that functions as an ARF6 effector. Constitutively active ARF6 reduces Rab35 loading into the endocytic pathway at clathrin-coated pits, causing endocytic recycling and cytokinesis defects identical to those of inactivated Rab35.","method":"Expression of constitutively active ARF6-Q67L; identification of EPI64B as ARF6 effector; Rab35-GTP levels; endocytic recycling assay; cytokinesis defect scoring","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — identification of effector linking ARF6 to Rab35 regulation plus functional cytokinesis and recycling readouts, mechanistically clear epistasis","pmids":["22226746"],"is_preprint":false},{"year":2011,"finding":"ARF6-GTP associates with clathrin-coated pits (CCPs) at the plasma membrane in an AP-2-dependent mechanism. In CCPs, ARF6-GTP mediates recruitment of JIP3 and JIP4 effectors after auxilin recruitment. ARF6 does not contribute to receptor-mediated clathrin-dependent endocytosis but instead ARF6-JIP interaction on endocytic vesicles is required for fast microtubule-dependent recycling of the transferrin receptor.","method":"TIRF microscopy of GFP-ARF6; AP-2 mutant analysis; ARF6-JIP interaction assays; transferrin receptor recycling assay","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — TIRF microscopy with multiple genetic controls, clear separation of activation from effector function, multiple orthogonal assays","pmids":["21439824"],"is_preprint":false},{"year":2012,"finding":"IL-1β signals through a NF-κB-independent MYD88-ARNO-ARF6 pathway to disrupt endothelial barrier function. ARNO binds directly to MYD88; this interaction activates ARF6, which disrupts endothelial cell-cell junctions. The ARF6-GEF inhibitor SecinH3 enhances vascular stability and improves outcomes in animal models of inflammatory arthritis and acute inflammation.","method":"Direct binding assay (MYD88-ARNO); ARF6 activation assay; dominant-negative constructs; SecinH3 pharmacological inhibition; in vitro permeability assay; in vivo inflammatory models","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein-protein binding plus genetic and pharmacological perturbation plus in vivo validation, published in Nature","pmids":["23143332"],"is_preprint":false},{"year":2012,"finding":"Rab35 suppresses ARF6 activity to maintain cadherins at the cell surface and inhibit cell migration. Rab35 knockdown de-represses ARF6, leading to increased β1-integrin and EGF receptor recycling and decreased E-cadherin at the surface, promoting an EMT-like state.","method":"siRNA knockdown of Rab35; ARF6 activity assay; β1-integrin and cadherin surface quantification; migration assay","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with biochemical ARF6 activity measurement and cargo trafficking readout, single lab","pmids":["23264734"],"is_preprint":false},{"year":2012,"finding":"ARF6 directs rapid axonal transport of α9β1 integrins in ARF6-positive vesicles. ARF6 inactivation (ACAP1 expression) increases β1 integrin recycling to the neuronal surface and increases anterograde axonal transport; ARF6 activation (ARNO or EFA6 expression) increases retrograde integrin transport and internalization. ARF6 inactivation increases integrin-mediated axon outgrowth.","method":"Live-cell imaging of integrin-GFP vesicles in DRG axons and PC12 cells; ACAP1, ARNO, EFA6 overexpression; integrin surface quantification; neurite outgrowth assay","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live-cell imaging of transport plus multiple GEF/GAP manipulations with functional axon growth readout, single lab","pmids":["22836268"],"is_preprint":false},{"year":2013,"finding":"AGAP3 is a component of the NMDA receptor complex and regulates NMDA receptor-mediated Ras/ERK and ARF6 signaling pathways during chemically induced LTP. AGAP3 knockdown occludes AMPA receptor trafficking during LTP, establishing AGAP3 as a link between NMDA receptor activation and ARF6-dependent AMPA receptor trafficking.","method":"Co-immunoprecipitation with NMDA receptor complex; siRNA knockdown; ARF6 activity assay; AMPA receptor trafficking assay during chemically-induced LTP in rat neurons","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus siRNA with functional synaptic plasticity readout, single lab","pmids":["23904596"],"is_preprint":false},{"year":2014,"finding":"ARF6 and its effector PLD2 control syntenin exosome biogenesis by regulating budding of intraluminal vesicles (ILVs) into multivesicular bodies (MVBs). ARF6 also controls EGF receptor degradation but does not affect HIV-1 budding, excluding a general effect on ESCRT.","method":"siRNA knockdown of ARF6 and PLD2; electron microscopy of MVBs and ILVs; exosome quantification; EGFR degradation assay; HIV-1 budding assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown with EM-based ILV quantification plus multiple cargo controls, published in Nature Communications","pmids":["24637612"],"is_preprint":false},{"year":2015,"finding":"ARF6 together with JIP3 and JIP4 effectors regulates MT1-MMP exocytosis for cancer cell invasion. JIPs are recruited by WASH on MT1-MMP endosomes and recruit dynein-dynactin and kinesin-1. Plasma membrane ARF6 interacts with endosomal JIPs to coordinate dynein-dynactin and kinesin-1 in a tug-of-war that drives MT1-MMP endosome tubulation and exocytosis. ARF6 or JIP3/4 silencing mispositiones MT1-MMP endosomes and reduces exocytosis and invasion.","method":"siRNA silencing; co-immunoprecipitation; live-cell imaging of MT1-MMP endosomes; MT1-MMP exocytosis assay; Matrigel invasion assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA plus Co-IP plus live-cell endosome imaging with exocytosis and invasion readouts, multiple orthogonal approaches","pmids":["26504170"],"is_preprint":false},{"year":2015,"finding":"Endothelial-specific deletion of ARF6 abolishes HGF-stimulated β1-integrin recycling and suppresses tumor neoangiogenesis and growth. GEFs GEP100, EFA6B, EFA6D, and Grp1 regulate HGF-stimulated β1-integrin recycling; pharmacological inhibition of the ARF6 GEF Grp1 suppresses tumor vascularization.","method":"Conditional endothelial-specific Arf6 knockout mice; β1-integrin recycling assay; tumor implantation model; Grp1 inhibitor pharmacology","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO in primary endothelial cells with in vivo tumor angiogenesis readout plus pharmacological validation","pmids":["26239146"],"is_preprint":false},{"year":2016,"finding":"Arf6 controls retromer trafficking via a phosphoinositide-based mechanism. Arf6 KO MEFs accumulate free cholesterol in late endosomes/lysosomes due to mistrafficking of NPC2, a cargo of CI-M6PR. This results from a selective increase in endosomal PI4P that perturbs retromer-mediated retrograde transport of CI-M6PR via SNX6 (a PI4P effector). Reducing PI4P in KO MEFs rescues retromer tubulation and cholesterol distribution.","method":"Inducible Arf6 knockout MEFs; PI4P immunofluorescence and quantification; retromer tubulation imaging; NPC2 trafficking assay; cholesterol staining; PI4P manipulation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible KO with multiple mechanistic readouts (PI4P, retromer, NPC2, cholesterol) and rescue experiment","pmids":["27336679"],"is_preprint":false},{"year":2016,"finding":"Arf6 controls platelet spreading and clot retraction via αIIbβ3 integrin trafficking. Arf6 KO platelets show reduced fibrinogen (Fg) uptake, deficient FITC-Fg internalization, enhanced spreading on Fg, and faster clot retraction, without changes in resting/activated αIIbβ3 levels, MLC phosphorylation, or Rac1/RhoA activation.","method":"Platelet-specific Arf6 conditional KO mice; biotinylated/FITC-Fg uptake in vivo and ex vivo; flow cytometry; immunofluorescence of Rab4/Rab11 vesicles; clot retraction assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO mouse model with multiple complementary functional assays and mechanistic controls","pmids":["26738539"],"is_preprint":false},{"year":2016,"finding":"LPA activates ARF6 via G-protein-coupled LPA receptors through GTP-Gα12 binding to EFA6 in renal cancer cells, promoting mesenchymal invasion. This is distinct from the GEP100-mediated activation seen in breast cancer cells.","method":"ARF6 activity assay; LPA stimulation; Gα12 dominant-negative; EFA6 co-immunoprecipitation; invasion assay","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical ARF6 activation assay plus Co-IP of pathway components plus functional invasion readout, single lab","pmids":["26854204"],"is_preprint":false},{"year":2016,"finding":"The mevalonate pathway enzyme GGT-II and its substrate Rab11b are required for ARF6 trafficking to the plasma membrane for activation by receptor tyrosine kinases. Mutant p53 promotes ARF6 activation by supporting GGT-II and Rab11b. MVP inhibition blocked invasion and metastasis only in cells overexpressing ARF6.","method":"GGT-II inhibitor; Rab11b siRNA; ARF6 plasma membrane localization imaging; invasion and metastasis assays; ARF6 activation assay","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and siRNA perturbation with ARF6 trafficking and activation readouts, single lab","pmids":["27044891"],"is_preprint":false},{"year":2017,"finding":"ARF6 controls VEGFR2 trafficking and signaling through two distinct GEFs: ARNO activates ARF6 to promote VEGFR2 internalization; GEP100 activates ARF6 to promote VEGFR2 recycling via coreceptor binding. Both pathways converge to determine VEGFR2 signal output and are targets for diabetic retinopathy intervention.","method":"In vitro, cellular, genetic (conditional KO), and pharmacological approaches; VEGFR2 trafficking assay; ARF6 activation assay; ARNO and GEP100 interaction with VEGFR2; in vivo retinopathy models","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including conditional KO, biochemistry, pharmacology, and in vivo models in a single study","pmids":["29058688"],"is_preprint":false},{"year":2018,"finding":"The Arf6-AMAP1 pathway promotes anterograde trafficking of mitochondria by promoting ILK localization to focal adhesions, thereby blocking RhoT1-TRAK2 (retrograde) association. This is required for avoiding detrimental ROS production during cell invasion.","method":"siRNA and dominant-mutant blocking of Arf6-AMAP1 pathway; mitochondria localization imaging; ROS measurement; ILK-focal adhesion immunofluorescence; TRAK1/2 co-immunoprecipitation with RhoT1; invasion assay","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic perturbations with mechanistic co-IP and functional cellular readouts, single lab","pmids":["29992963"],"is_preprint":false},{"year":2018,"finding":"Microexon switching in the ARF6 GEF cytohesin-1 controls Met-dependent cell migration. Diglycine (microexon-skipped) isoform has differential affinity for PI(3,4,5)P3 vs. triglycine isoform (PI(4,5)P2), directing distinct subcellular localizations—triglycine to plasma membrane, diglycine to leading edge—thereby spatially restricting ARF6 activation and downstream HGF/Met-dependent migration.","method":"Phosphoinositide-binding assay; subcellular localization imaging; Met receptor co-immunoprecipitation; microexon isoform rescue; cell migration assay","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical PI-binding assay plus live-cell localization plus functional migration rescue, single lab","pmids":["30404949"],"is_preprint":false},{"year":2019,"finding":"ARF6-GTP forms a cytoplasmic shuttle with GRP1 that captures pre-miRNA/Exportin-5 complex following Ran-GTP dissociation after nuclear export, delivering pre-miRNA cargo to nascent tumor microvesicles. ARF6 activation increases pre-miRNA content in TMVs through a process requiring casein kinase 2-mediated phosphorylation of RanGAP1.","method":"Co-immunoprecipitation of ARF6-GTP, GRP1, Exportin-5, pre-miRNA; ARF6 activation manipulation; CK2 inhibition/mutation; TMV pre-miRNA quantification","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple Co-IPs plus mechanistic CK2 phosphorylation step plus functional cargo quantification, published in Nature Cell Biology","pmids":["31235936"],"is_preprint":false},{"year":2019,"finding":"Arf6 is required for commissural axon midline crossing; Slit-Robo1 signaling activates Arf6 via cytohesins. Arf6 mediates endocytosis and recycling of Robo1 receptor, which maintains receptor stability during Slit stimulation. A positive feedback loop is established: Robo1 endocytosis triggers Arf6-mediated amplification of Slit response.","method":"Arf6-knockout mice (commissural axon phenotype); cytohesin dominant-negative; Robo1 endocytosis/recycling assay; ARF6 activation assay; in vivo axon guidance imaging","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout mouse with in vivo axon guidance phenotype plus biochemical endocytosis/recycling assays","pmids":["30674481"],"is_preprint":false},{"year":2019,"finding":"ARF6 forms a complex with RhoB; the GCI residues (188-190) of RhoB mediate this interaction. Targeting ARF6 to plasma membrane or mitochondrial membranes promotes co-recruitment of RhoB. ARF6 depletion causes RhoB loss from endosomal membranes and RhoB degradation via an endolysosomal pathway, resulting in defective actin and focal adhesion dynamics.","method":"Co-immunoprecipitation; ARF6 targeted to specific membranes; confocal imaging of RhoB localization; ARF6 KD; RhoB degradation assay; focal adhesion imaging","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus targeted ARF6 experiments with RhoB localization and degradation readouts, single lab","pmids":["31591185"],"is_preprint":false},{"year":2019,"finding":"Arf6 and macropinocytosis machinery (JIP3, dynein) shape macropinosome formation and inward movement. Arf6 and JIP3 (a microtubule motor scaffold/ARF6 effector) are required for sealing and transport of macropinosomes through the actin-myosin-rich lamellar region along microtubule tracks.","method":"siRNA knockdown of Arf6, JIP3, dynein; live-cell imaging of macropinosome formation and transport; microtubule depolymerization","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdowns with live-cell imaging in multiple conditions, single lab","pmids":["30969891"],"is_preprint":false},{"year":2019,"finding":"KRAS promotes ARF6 mRNA translation through eIF4A-dependent mechanism involving a G-quadruplex structure in the 5'-UTR of ARF6 mRNA, by inducing TEAD3 and ETV4 to suppress PDCD4. TP53 facilitates ARF6 activation by PDGF via promoting PDGFRβ expression and mevalonate pathway enzymes.","method":"Translational reporter for ARF6 5'-UTR; eIF4A inhibitor silvestrol; PDCD4 knockdown; ARF6 activity assay upon PDGF stimulation; KPC mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — translational reporter assay plus eIF4A inhibition plus in vivo KPC model, single lab","pmids":["31399545"],"is_preprint":false},{"year":2022,"finding":"N-myristoylated ARF6 recognizes palmitoylated EGFR via lipid-lipid interaction, recruits the exocyst complex to promote EGFR budding from the Golgi, and facilitates EGFR transport to the plasma membrane in its GTP-bound form. DHHC13 palmitoylates EGFR, which is critical for plasma membrane localization.","method":"Co-immunoprecipitation; lipid-lipid interaction assay; EGFR palmitoylation assay (DHHC13 identification); exocyst recruitment assay; plasma membrane EGFR localization; cell-permeable peptide (GKVL-TAT) disrupting this interaction","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus lipid interaction assay plus functional EGFR sorting readout, single lab","pmids":["36224181"],"is_preprint":false},{"year":2022,"finding":"ARF6-mediated recruitment of PIP5K1C converts PI(4)P to PI(4,5)P2 on late-stage vesicles near the plasma membrane, driving exocyst recruitment and membrane tethering. Reconstitution of functional octameric human exocyst demonstrated that each subcomplex independently binds PI(4,5)P2 for membrane tethering.","method":"Reconstitution of functional octameric exocyst; in vitro membrane tethering assay; PI(4,5)P2 binding assay; ARF6-PIP5K1C membrane recruitment experiment; epithelial cell biology validation","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of exocyst tethering plus biochemical lipid binding plus cell-based validation, multiple orthogonal methods","pmids":["35609603"],"is_preprint":false},{"year":2022,"finding":"DDR1 activates ARF6 by recruiting the GEF PSD4 in a collagen-stimulated, DDR1 kinase-dependent manner in hepatocellular carcinoma cells. DDR1 physically interacts with ARF6 (co-immunoprecipitation). DDR1 kinase activity is required for ARF6 activation.","method":"Co-immunoprecipitation; kinase-dead DDR1 mutant; ARF6 activity assay; PSD4 recruitment assay; invasion and metastasis assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus kinase mutant plus ARF6 activity assay with metastasis readout, single lab","pmids":["35140331"],"is_preprint":false},{"year":2023,"finding":"LRRK2-hyperphosphorylated RABs disrupt autophagosome axonal transport by disrupting coordinated regulation of dynein and kinesin. ARF6 overexpression attenuates transport defects in LRRK2-p.R1441H knockin and PPM1H knockout neurons, acting as a switch for selective activation of dynein or kinesin.","method":"iPSC-derived human neurons with LRRK2-p.R1441H knockin; PPM1H knockout; ARF6 overexpression rescue; live-cell imaging of autophagosome transport","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — iPSC-derived neurons with knockin mutation plus ARF6 rescue with live-cell transport imaging, single lab","pmids":["37133994"],"is_preprint":false}],"current_model":"ARF6 is a small GTPase that cycles between GDP- and GTP-bound states at the plasma membrane and endosomal compartments, where it orchestrates membrane trafficking (clathrin-independent endocytosis and recycling, integrin and receptor recycling, microvesicle shedding, exosome biogenesis, macropinocytosis), actin cytoskeleton remodeling, and signaling by activating downstream effectors including PIP5K (generating PI(4,5)P2), phospholipase D2, the exocyst complex, and JIP3/JIP4 motor scaffold proteins; its GTP/GDP cycle is controlled by a repertoire of GEFs (ARNO/cytohesin-2, GEP100/BRAG2, EFA6, GRP1) and GAPs (ACAP1/2/4, ARAP2, GIT1, EPI64B), and is regulated post-translationally by Fbx8-mediated ubiquitination and upstream by receptor tyrosine kinases (EGFR, VEGFR2, Met, DDR1), GPCRs (LH/CGR, AT1R, CaSR, P2Y), Gαq, and the mevalonate pathway, enabling ARF6 to control diverse processes including cancer invasion and metastasis (via integrin/MT1-MMP recycling, microvesicle release, and PD-L1 dynamics), cytokinesis, dendritic spine formation, axon guidance, vascular stability, and cholesterol homeostasis."},"narrative":{"mechanistic_narrative":"ARF6 is a small GTPase of the endosomal/plasma membrane system whose GTP/GDP cycle governs clathrin-independent endocytosis, cargo recycling, actin remodeling, and regulated membrane budding, distinct from Golgi-associated ARF function [PMID:7896867]. A central output of activated ARF6 is the local generation of phosphoinositides: ARF6-GTP recruits and activates PIP5K to produce PI(4,5)P2 at the plasma membrane and on tubular endosomes, and PI(4,5)P2 turnover driven by the GTPase cycle is required for cargo recycling, with constitutively active ARF6 trapping integrins and other surface proteins in PI(4,5)P2-positive, actin-coated vacuoles [PMID:11535619]; ARF6 inactivation and acquisition of PI3P in turn permit fusion of non-clathrin endosomes with the EEA1 pathway [PMID:12589044], and loss of ARF6 perturbs endosomal PI4P to disrupt retromer-mediated retrograde transport and cholesterol distribution [PMID:27336679]. ARF6 also activates phospholipase D2 in cholesterol-dependent microdomains [PMID:15759270] and recruits the exocyst complex via PIP5K1C-generated PI(4,5)P2 to tether vesicles at the plasma membrane [PMID:35609603]. Through these activities ARF6 controls receptor and integrin endocytosis/recycling—including β1-integrin handled via the GEF BRAG2/GEP100 [PMID:16461286] and recycling coordinated by ARF6-GTP binding of clathrin and JIP3/JIP4 motor scaffolds on endocytic vesicles for microtubule-dependent transferrin receptor recycling [PMID:21439824]. ARF6 drives cancer cell invasion by directing MT1-MMP endosome exocytosis through JIP3/JIP4–dynein/kinesin coordination [PMID:26504170] and by promoting protease-loaded microvesicle shedding via a PLD–ERK–MLCK cascade [PMID:19896381], and its release of pre-miRNA-loaded tumor microvesicles requires a GRP1/Exportin-5 shuttle [PMID:31235936]. Its cycle is set by ARF6-specific GAPs including ACAP1/2 and ACAP4 [PMID:11062263, PMID:16737952] and a diverse repertoire of GEFs (ARNO, GEP100, EFA6, GRP1, PSD4) acting downstream of receptors such as EGFR, VEGFR2, Met, DDR1, GPCRs, and Gαq [PMID:19416474, PMID:29058688, PMID:35140331], and is further tuned by Fbx8-mediated ubiquitination that inactivates ARF6 [PMID:18094045] and by reciprocal antagonism with Rab35 [PMID:22226746, PMID:23264734]. Physiologically, endothelial ARF6 supports HGF-stimulated β1-integrin recycling and tumor neoangiogenesis [PMID:26239146], ARF6 controls platelet integrin trafficking and clot retraction [PMID:26738539], maintains endothelial barrier integrity downstream of IL-1β/MYD88/ARNO [PMID:23143332], and is required for cytokinesis [PMID:16181626, PMID:22226746], dendritic spine formation [PMID:16672654], and commissural axon midline crossing via Robo1 recycling [PMID:30674481].","teleology":[{"year":1995,"claim":"Established that ARF6 acts in the endosomal/plasma membrane system rather than the Golgi, defining its compartment and showing that its GTPase state dictates membrane morphology.","evidence":"Immuno-EM and immunofluorescence of epitope-tagged wild-type and GTPase-mutant ARF6","pmids":["7896867"],"confidence":"High","gaps":["Did not identify effectors linking GTP state to membrane remodeling","Cargo-level consequences not yet defined"]},{"year":2001,"claim":"Identified PI(4,5)P2 generation via PIP5K as the central lipid output of the ARF6 cycle controlling recycling, explaining how the GTPase remodels membranes.","evidence":"GFP-PH PI(4,5)P2 reporter with ARF6 mutants and EFA6 in cultured cells","pmids":["11535619"],"confidence":"High","gaps":["Direct biochemical PIP5K activation kinetics not resolved here","How PI(4,5)P2 turnover is coupled to specific recycling steps unclear"]},{"year":2000,"claim":"Defined the GAP arm of the cycle by showing ACAP1/2 are ARF6-specific, PI-dependent GAPs acting peripherally, the first specific ARF6 inactivators.","evidence":"In vitro GAP assays with substrate specificity plus cell-based protrusion readout","pmids":["11062263"],"confidence":"High","gaps":["Spatial recruitment cues for ACAPs in vivo not fully defined"]},{"year":2003,"claim":"Showed ARF6 inactivation and PI3P acquisition are required for non-clathrin endosomes to converge with the canonical EEA1 early-endosome pathway, positioning the cycle within endosome maturation.","evidence":"ARF6 mutants plus PI3-kinase inhibitors with defined cargo readouts","pmids":["12589044"],"confidence":"Medium","gaps":["GAP responsible for inactivation step not identified","Single lab"]},{"year":2006,"claim":"Resolved spatiotemporal control of ARF6 in living cells, showing activation restricted to leading edges and switching to ARF1 downstream of a PI3K signal during phagocytosis.","evidence":"FRET stoichiometric microscopy of ARF chimeras with PI3K inhibition","pmids":["16669702"],"confidence":"High","gaps":["GEF/GAP identities producing the spatial gradient not pinned down"]},{"year":2006,"claim":"Connected receptor trafficking machinery to ARF6 by identifying ARNO-V-ATPase coupling as an acidification-sensitive control point for endosomal progression.","evidence":"Reciprocal Co-IP, bafilomycin, dominant-negatives, endocytosis assays","pmids":["16415858"],"confidence":"High","gaps":["How acidification state is transduced to GEF activity mechanistically unclear"]},{"year":2006,"claim":"Demonstrated ARF6 controls β1-integrin endocytosis and recycling via the GEF BRAG2/GEP100, linking the cycle to adhesion dynamics.","evidence":"siRNA of GEF and GTPase with reciprocal surface/internal integrin phenotypes","pmids":["16461286"],"confidence":"High","gaps":["Structural basis of BRAG2 selectivity for ARF6 not addressed"]},{"year":2009,"claim":"Defined a linear ARF6-GTP→PLD→ERK→MLCK→MLC cascade driving protease-loaded microvesicle shedding, mechanistically tying ARF6 to tumor microvesicle biogenesis.","evidence":"ARF6 mutants with PLD, ERK, MLCK inhibition and vesicle quantification","pmids":["19896381"],"confidence":"High","gaps":["Cargo selection into microvesicles not fully resolved"]},{"year":2011,"claim":"Separated ARF6 activation at clathrin-coated pits from its effector role, showing ARF6-JIP recruitment drives microtubule-dependent fast recycling rather than endocytosis itself.","evidence":"TIRF microscopy of GFP-ARF6 with AP-2 mutants and recycling assays","pmids":["21439824"],"confidence":"High","gaps":["How AP-2 selects ARF6-GTP at CCPs mechanistically undefined"]},{"year":2011,"claim":"Placed ARF6 in reciprocal antagonism with Rab35 by identifying EPI64B as an ARF6 effector that is a Rab35-GAP, linking the two GTPases in recycling and cytokinesis.","evidence":"Constitutively active ARF6, effector identification, Rab35-GTP and cytokinesis readouts","pmids":["22226746"],"confidence":"High","gaps":["Reciprocal Rab35-driven ARF6 suppression mechanism addressed separately"]},{"year":2012,"claim":"Extended ARF6 to vascular physiology by showing IL-1β acts through a MYD88-ARNO-ARF6 axis to disrupt endothelial junctions, validated pharmacologically in vivo.","evidence":"Direct MYD88-ARNO binding, SecinH3 inhibition, permeability and in vivo inflammation models","pmids":["23143332"],"confidence":"High","gaps":["Junctional cargo internalized by ARF6 not enumerated here"]},{"year":2014,"claim":"Defined ARF6/PLD2 control of intraluminal vesicle budding into MVBs for syntenin exosome biogenesis, distinct from general ESCRT-dependent budding.","evidence":"siRNA of ARF6/PLD2 with EM of ILVs and cargo controls (EGFR, HIV-1)","pmids":["24637612"],"confidence":"High","gaps":["How ARF6/PLD2 lipids drive inward budding topologically unresolved"]},{"year":2015,"claim":"Explained how ARF6 drives invasion by coordinating JIP3/JIP4 with dynein-dynactin and kinesin-1 in a motor tug-of-war driving MT1-MMP endosome exocytosis.","evidence":"siRNA, Co-IP, live-cell endosome imaging, exocytosis and invasion assays","pmids":["26504170"],"confidence":"High","gaps":["Quantitative balance of motor forces not measured"]},{"year":2015,"claim":"Demonstrated in vivo that endothelial ARF6 is required for HGF-stimulated β1-integrin recycling and tumor neoangiogenesis, with multiple GEFs and Grp1 as a druggable node.","evidence":"Endothelial-specific Arf6 conditional KO mice, recycling assays, tumor models, Grp1 inhibitor","pmids":["26239146"],"confidence":"High","gaps":["Relative contributions of individual GEFs in vivo not separated"]},{"year":2016,"claim":"Linked ARF6 to lipid/cholesterol homeostasis by showing Arf6 loss elevates endosomal PI4P, disrupting SNX6/retromer retrograde transport of CI-M6PR and NPC2.","evidence":"Inducible Arf6 KO MEFs with PI4P, retromer tubulation, NPC2 and cholesterol readouts plus rescue","pmids":["27336679"],"confidence":"High","gaps":["How ARF6 limits endosomal PI4P levels biochemically unresolved"]},{"year":2016,"claim":"Established physiological roles in hemostasis, showing platelet Arf6 controls αIIbβ3-mediated fibrinogen uptake, spreading and clot retraction.","evidence":"Platelet-specific Arf6 KO mice with fibrinogen uptake, spreading and clot retraction assays","pmids":["26738539"],"confidence":"High","gaps":["GEF/GAP controlling platelet ARF6 not identified"]},{"year":2017,"claim":"Showed two GEFs route ARF6 to opposite VEGFR2 fates—ARNO to internalization, GEP100 to recycling—integrating signal output, with relevance to retinopathy.","evidence":"Conditional KO, biochemistry, pharmacology, and in vivo retinopathy models","pmids":["29058688"],"confidence":"High","gaps":["How GEF choice is biased at a given receptor pool unclear"]},{"year":2019,"claim":"Defined a non-trafficking role: an ARF6-GTP/GRP1 shuttle captures pre-miRNA/Exportin-5 for delivery into tumor microvesicles, regulated by CK2 phosphorylation of RanGAP1.","evidence":"Co-IPs of ARF6-GTP/GRP1/Exportin-5/pre-miRNA with CK2 perturbation and TMV cargo quantification","pmids":["31235936"],"confidence":"High","gaps":["How cytoplasmic ARF6-GTP intercepts the export complex spatially undefined"]},{"year":2019,"claim":"Established an in vivo neurodevelopmental role, showing Arf6 mediates Robo1 endocytosis/recycling for commissural axon midline crossing via a Slit-driven positive feedback loop.","evidence":"Arf6 KO mice, cytohesin dominant-negatives, Robo1 trafficking and in vivo axon guidance","pmids":["30674481"],"confidence":"High","gaps":["Mechanism of feedback amplification not fully dissected"]},{"year":2022,"claim":"Reconstituted how ARF6 promotes exocyst-mediated tethering, recruiting PIP5K1C to generate PI(4,5)P2 that engages each exocyst subcomplex for membrane attachment.","evidence":"Reconstituted octameric exocyst, in vitro tethering and lipid binding, ARF6-PIP5K1C recruitment, cell validation","pmids":["35609603"],"confidence":"High","gaps":["Direct ARF6-exocyst contacts vs. lipid-mediated recruitment not fully separated"]},{"year":null,"claim":"How the diverse GEF/GAP repertoire, post-translational modifications, and lipid microenvironments are integrated to specify ARF6 activation at a precise location, time, and cargo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of GEF/GAP selection per stimulus","Structural basis of ARF6 effector switching incompletely defined","In vivo cargo-specific recycling itineraries largely uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,3,8,16,17]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[15,28,47,57]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,18,34,56]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,3,35]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0,4,35,43]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[35,41,50]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[3,10]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,4,13,35,41]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[35,38,47,55]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[28,36,47,51]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3,10,34]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[9,27,41,42]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[43,46,54]}],"complexes":["exocyst"],"partners":["ARNO","GEP100","EFA6","GRP1","ACAP1","JIP3","JIP4","RHOB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P62330","full_name":"ADP-ribosylation factor 6","aliases":[],"length_aa":175,"mass_kda":20.1,"function":"GTP-binding protein involved in protein trafficking that regulates endocytic recycling and cytoskeleton remodeling (PubMed:11266366, PubMed:16737952, PubMed:18400762, PubMed:21170023, PubMed:32103017, PubMed:7589240). GTP-bound form plays an important role in the transport of multiple palmitoylated proteins form the Golgi to the plasma membrane (PubMed:37461827). Required for normal completion of mitotic cytokinesis (By similarity). Plays a role in the reorganization of the actin cytoskeleton and the formation of stress fibers (By similarity). Involved in the regulation of dendritic spine development, contributing to the regulation of dendritic branching and filopodia extension (PubMed:14978216). Potentiates the neurite outgrowth in primary neurons by interacting with the molecular adapter APBB1 (PubMed:36250347). Plays an important role in membrane trafficking, during junctional remodeling and epithelial polarization (PubMed:36017701). Regulates surface levels of adherens junction proteins such as CDH1 (By similarity). Required for NTRK1 sorting to the recycling pathway from early endosomes (By similarity) (Microbial infection) Functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase (Microbial infection) Plays a key role in the endocytosis of enterovirus 71 and thus viral entry into brain microvascular endothelial cells","subcellular_location":"Cytoplasm, cytosol; Cell membrane; Endosome membrane; Recycling endosome membrane; Cell projection, filopodium membrane; Cell projection, ruffle; Cleavage furrow; Midbody, Midbody ring; Early endosome membrane; Golgi apparatus, trans-Golgi network membrane","url":"https://www.uniprot.org/uniprotkb/P62330/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARF6","classification":"Not Classified","n_dependent_lines":319,"n_total_lines":1208,"dependency_fraction":0.2640728476821192},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000165527","cell_line_id":"CID000657","localizations":[{"compartment":"membrane","grade":3},{"compartment":"cytoplasmic","grade":2}],"interactors":[{"gene":"SMARCD2","stoichiometry":0.2},{"gene":"COPB2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000657","total_profiled":1310},"omim":[{"mim_id":"620656","title":"PLECKSTRIN AND SEC7 DOMAINS-CONTAINING PROTEIN 2; PSD2","url":"https://www.omim.org/entry/620656"},{"mim_id":"619948","title":"INTERACTION PROTEIN FOR CYTOHESIN EXCHANGE FACTORS 1; IPCEF1","url":"https://www.omim.org/entry/619948"},{"mim_id":"618051","title":"INNATE IMMUNITY ACTIVATOR; INAVA","url":"https://www.omim.org/entry/618051"},{"mim_id":"617476","title":"CNKSR FAMILY, MEMBER 3; CNKSR3","url":"https://www.omim.org/entry/617476"},{"mim_id":"616916","title":"SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; SMAP2","url":"https://www.omim.org/entry/616916"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARF6"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P62330","domains":[{"cath_id":"3.40.50.300","chopping":"15-175","consensus_level":"medium","plddt":96.5805,"start":15,"end":175}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P62330","model_url":"https://alphafold.ebi.ac.uk/files/AF-P62330-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P62330-F1-predicted_aligned_error_v6.png","plddt_mean":94.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARF6","jax_strain_url":"https://www.jax.org/strain/search?query=ARF6"},"sequence":{"accession":"P62330","fasta_url":"https://rest.uniprot.org/uniprotkb/P62330.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P62330/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P62330"}},"corpus_meta":[{"pmid":"19896381","id":"PMC_19896381","title":"ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles.","date":"2009","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/19896381","citation_count":698,"is_preprint":false},{"pmid":"16107481","id":"PMC_16107481","title":"Auxin response factors ARF6 and ARF8 promote jasmonic acid production and flower maturation.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16107481","citation_count":509,"is_preprint":false},{"pmid":"24637612","id":"PMC_24637612","title":"Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24637612","citation_count":456,"is_preprint":false},{"pmid":"16415858","id":"PMC_16415858","title":"V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16415858","citation_count":396,"is_preprint":false},{"pmid":"11535619","id":"PMC_11535619","title":"Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11535619","citation_count":375,"is_preprint":false},{"pmid":"7896867","id":"PMC_7896867","title":"Overexpression of wild-type and mutant ARF1 and ARF6: distinct perturbations of nonoverlapping membrane compartments.","date":"1995","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7896867","citation_count":333,"is_preprint":false},{"pmid":"12589044","id":"PMC_12589044","title":"Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12589044","citation_count":235,"is_preprint":false},{"pmid":"15087504","id":"PMC_15087504","title":"Requirement for Arf6 in breast cancer invasive activities.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15087504","citation_count":222,"is_preprint":false},{"pmid":"11062263","id":"PMC_11062263","title":"ACAPs are arf6 GTPase-activating proteins that function in the cell periphery.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11062263","citation_count":169,"is_preprint":false},{"pmid":"14565977","id":"PMC_14565977","title":"ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/14565977","citation_count":141,"is_preprint":false},{"pmid":"23143332","id":"PMC_23143332","title":"Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23143332","citation_count":140,"is_preprint":false},{"pmid":"20727515","id":"PMC_20727515","title":"TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20727515","citation_count":131,"is_preprint":false},{"pmid":"22226746","id":"PMC_22226746","title":"An ARF6/Rab35 GTPase cascade for endocytic recycling and successful cytokinesis.","date":"2012","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/22226746","citation_count":129,"is_preprint":false},{"pmid":"20837153","id":"PMC_20837153","title":"ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis.","date":"2010","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20837153","citation_count":126,"is_preprint":false},{"pmid":"31399545","id":"PMC_31399545","title":"ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31399545","citation_count":119,"is_preprint":false},{"pmid":"31235936","id":"PMC_31235936","title":"An ARF6-Exportin-5 axis delivers pre-miRNA cargo to tumour microvesicles.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31235936","citation_count":114,"is_preprint":false},{"pmid":"26504170","id":"PMC_26504170","title":"ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26504170","citation_count":110,"is_preprint":false},{"pmid":"23264734","id":"PMC_23264734","title":"Interplay between Rab35 and Arf6 controls cargo recycling to coordinate cell adhesion and migration.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23264734","citation_count":106,"is_preprint":false},{"pmid":"16461286","id":"PMC_16461286","title":"The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins.","date":"2006","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16461286","citation_count":101,"is_preprint":false},{"pmid":"16669702","id":"PMC_16669702","title":"A phosphatidylinositol-3-kinase-dependent signal transition regulates ARF1 and ARF6 during Fcgamma receptor-mediated phagocytosis.","date":"2006","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/16669702","citation_count":100,"is_preprint":false},{"pmid":"19416474","id":"PMC_19416474","title":"The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis.","date":"2009","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/19416474","citation_count":98,"is_preprint":false},{"pmid":"14607973","id":"PMC_14607973","title":"Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion.","date":"2003","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14607973","citation_count":96,"is_preprint":false},{"pmid":"12016212","id":"PMC_12016212","title":"Localization and activation of the ARF6 GTPase during cleavage furrow ingression and cytokinesis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12016212","citation_count":94,"is_preprint":false},{"pmid":"16672654","id":"PMC_16672654","title":"ARF6 and EFA6A regulate the development and maintenance of dendritic spines.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16672654","citation_count":91,"is_preprint":false},{"pmid":"26854204","id":"PMC_26854204","title":"Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26854204","citation_count":88,"is_preprint":false},{"pmid":"32368394","id":"PMC_32368394","title":"Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.","date":"2020","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32368394","citation_count":82,"is_preprint":false},{"pmid":"20713492","id":"PMC_20713492","title":"Induction of nonapoptotic cell death by activated Ras requires inverse regulation of Rac1 and Arf6.","date":"2010","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/20713492","citation_count":82,"is_preprint":false},{"pmid":"22836268","id":"PMC_22836268","title":"ARF6 directs axon transport and traffic of integrins and regulates axon growth in adult DRG neurons.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22836268","citation_count":79,"is_preprint":false},{"pmid":"12609992","id":"PMC_12609992","title":"Modulation of Rac1 and ARF6 activation during epithelial cell scattering.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12609992","citation_count":78,"is_preprint":false},{"pmid":"28625359","id":"PMC_28625359","title":"Roles of Arf6 in cancer cell invasion, metastasis and proliferation.","date":"2017","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28625359","citation_count":75,"is_preprint":false},{"pmid":"16636148","id":"PMC_16636148","title":"A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16636148","citation_count":73,"is_preprint":false},{"pmid":"12925676","id":"PMC_12925676","title":"Arf6 and phosphoinositol-4-phosphate-5-kinase activities permit bypass of the Rac1 requirement for beta1 integrin-mediated bacterial uptake.","date":"2003","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12925676","citation_count":72,"is_preprint":false},{"pmid":"29992963","id":"PMC_29992963","title":"Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29992963","citation_count":69,"is_preprint":false},{"pmid":"31060328","id":"PMC_31060328","title":"The Small GTPase Arf6: An Overview of Its Mechanisms of Action and of Its Role in Host⁻Pathogen Interactions and Innate Immunity.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31060328","citation_count":68,"is_preprint":false},{"pmid":"17662026","id":"PMC_17662026","title":"Mucolipin-2 localizes to the Arf6-associated pathway and regulates recycling of GPI-APs.","date":"2007","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/17662026","citation_count":68,"is_preprint":false},{"pmid":"15775968","id":"PMC_15775968","title":"Thyrotropin receptor trafficking relies on the hScrib-betaPIX-GIT1-ARF6 pathway.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15775968","citation_count":64,"is_preprint":false},{"pmid":"19193766","id":"PMC_19193766","title":"EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19193766","citation_count":61,"is_preprint":false},{"pmid":"23904596","id":"PMC_23904596","title":"AGAP3 and Arf6 regulate trafficking of AMPA receptors and synaptic plasticity.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23904596","citation_count":58,"is_preprint":false},{"pmid":"26738539","id":"PMC_26738539","title":"Arf6 controls platelet spreading and clot retraction via integrin αIIbβ3 trafficking.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26738539","citation_count":58,"is_preprint":false},{"pmid":"26239146","id":"PMC_26239146","title":"Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial β1 integrin recycling.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26239146","citation_count":57,"is_preprint":false},{"pmid":"21858086","id":"PMC_21858086","title":"GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21858086","citation_count":57,"is_preprint":false},{"pmid":"20945365","id":"PMC_20945365","title":"Regulation of PIP5K activity by Arf6 and its physiological significance.","date":"2011","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20945365","citation_count":56,"is_preprint":false},{"pmid":"16181626","id":"PMC_16181626","title":"A requirement for ARF6 during the completion of cytokinesis.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16181626","citation_count":54,"is_preprint":false},{"pmid":"21439824","id":"PMC_21439824","title":"Decoupling of activation and effector binding underlies ARF6 priming of fast endocytic recycling.","date":"2011","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/21439824","citation_count":54,"is_preprint":false},{"pmid":"27044891","id":"PMC_27044891","title":"P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27044891","citation_count":52,"is_preprint":false},{"pmid":"26379158","id":"PMC_26379158","title":"The Role of ARF6 in Biliary Atresia.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26379158","citation_count":51,"is_preprint":false},{"pmid":"17363898","id":"PMC_17363898","title":"ARF6-dependent activation of ERK and Rac1 modulates epithelial tubule development.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17363898","citation_count":51,"is_preprint":false},{"pmid":"30582444","id":"PMC_30582444","title":"CLIC4/Arf6 Pathway.","date":"2019","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/30582444","citation_count":48,"is_preprint":false},{"pmid":"16737952","id":"PMC_16737952","title":"Proteomic identification and functional characterization of a novel ARF6 GTPase-activating protein, ACAP4.","date":"2006","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/16737952","citation_count":46,"is_preprint":false},{"pmid":"29058688","id":"PMC_29058688","title":"Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29058688","citation_count":45,"is_preprint":false},{"pmid":"27336679","id":"PMC_27336679","title":"Arf6 controls retromer traffic and intracellular cholesterol distribution via a phosphoinositide-based mechanism.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27336679","citation_count":44,"is_preprint":false},{"pmid":"35140331","id":"PMC_35140331","title":"DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35140331","citation_count":43,"is_preprint":false},{"pmid":"36224181","id":"PMC_36224181","title":"Targeting EGFR-dependent tumors by disrupting an ARF6-mediated sorting system.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36224181","citation_count":43,"is_preprint":false},{"pmid":"21795701","id":"PMC_21795701","title":"Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21795701","citation_count":43,"is_preprint":false},{"pmid":"24835390","id":"PMC_24835390","title":"ARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24835390","citation_count":42,"is_preprint":false},{"pmid":"28495929","id":"PMC_28495929","title":"Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28495929","citation_count":42,"is_preprint":false},{"pmid":"16413267","id":"PMC_16413267","title":"Preparation of myristoylated Arf1 and Arf6.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16413267","citation_count":41,"is_preprint":false},{"pmid":"30969891","id":"PMC_30969891","title":"Arf6, JIP3, and dynein shape and mediate macropinocytosis.","date":"2019","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/30969891","citation_count":40,"is_preprint":false},{"pmid":"24255739","id":"PMC_24255739","title":"Arf6, Rab11 and transferrin receptor define distinct populations of recycling endosomes.","date":"2013","source":"Communicative & integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/24255739","citation_count":40,"is_preprint":false},{"pmid":"17623778","id":"PMC_17623778","title":"The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17623778","citation_count":40,"is_preprint":false},{"pmid":"12067715","id":"PMC_12067715","title":"ARF6: a newly appreciated player in G protein-coupled receptor desensitization.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12067715","citation_count":36,"is_preprint":false},{"pmid":"35609603","id":"PMC_35609603","title":"A mechanism for exocyst-mediated tethering via Arf6 and PIP5K1C-driven phosphoinositide conversion.","date":"2022","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/35609603","citation_count":36,"is_preprint":false},{"pmid":"28001501","id":"PMC_28001501","title":"The small GTPase ARF6 regulates protein trafficking to control cellular function during development and in disease.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/28001501","citation_count":34,"is_preprint":false},{"pmid":"31752956","id":"PMC_31752956","title":"Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31752956","citation_count":33,"is_preprint":false},{"pmid":"11516649","id":"PMC_11516649","title":"Crosstalk between ARF6 and protein kinase Calpha in Fc(gamma)RI-mediated activation of phospholipase D1.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11516649","citation_count":33,"is_preprint":false},{"pmid":"29388044","id":"PMC_29388044","title":"MiR-145 improves macrophage-mediated inflammation through targeting Arf6.","date":"2018","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/29388044","citation_count":33,"is_preprint":false},{"pmid":"21790911","id":"PMC_21790911","title":"Distinct roles of Rab11 and Arf6 in the regulation of Rab11-FIP3/arfophilin-1 localization in mitotic cells.","date":"2011","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/21790911","citation_count":33,"is_preprint":false},{"pmid":"17719203","id":"PMC_17719203","title":"ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin.","date":"2007","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/17719203","citation_count":33,"is_preprint":false},{"pmid":"18286566","id":"PMC_18286566","title":"A role for ARF6 in dendritic cell podosome formation and migration.","date":"2008","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18286566","citation_count":32,"is_preprint":false},{"pmid":"35399607","id":"PMC_35399607","title":"CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway.","date":"2022","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/35399607","citation_count":31,"is_preprint":false},{"pmid":"26170135","id":"PMC_26170135","title":"Arf6 controls beta-amyloid production by regulating macropinocytosis of the Amyloid Precursor Protein to lysosomes.","date":"2015","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/26170135","citation_count":31,"is_preprint":false},{"pmid":"37133994","id":"PMC_37133994","title":"Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37133994","citation_count":30,"is_preprint":false},{"pmid":"14684384","id":"PMC_14684384","title":"Differential expression and targeting of endogenous Arf1 and Arf6 small GTPases in kidney epithelial cells in situ.","date":"2003","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14684384","citation_count":29,"is_preprint":false},{"pmid":"26909552","id":"PMC_26909552","title":"Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/26909552","citation_count":29,"is_preprint":false},{"pmid":"15759270","id":"PMC_15759270","title":"Localization and regulation of phospholipase D2 by ARF6.","date":"2005","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15759270","citation_count":29,"is_preprint":false},{"pmid":"17398097","id":"PMC_17398097","title":"Regulation of Arf6 and ACAP1 signaling by the PTB-domain-containing adaptor protein GULP.","date":"2007","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/17398097","citation_count":28,"is_preprint":false},{"pmid":"23295182","id":"PMC_23295182","title":"ARAP2 signals through Arf6 and Rac1 to control focal adhesion morphology.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23295182","citation_count":27,"is_preprint":false},{"pmid":"18094045","id":"PMC_18094045","title":"Fbx8 makes Arf6 refractory to function via ubiquitination.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18094045","citation_count":27,"is_preprint":false},{"pmid":"16650966","id":"PMC_16650966","title":"ARF6 activation by Galpha q signaling: Galpha q forms molecular complexes with ARNO and ARF6.","date":"2006","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16650966","citation_count":27,"is_preprint":false},{"pmid":"21883766","id":"PMC_21883766","title":"Rac1 and calmodulin interactions modulate dynamics of ARF6-dependent endocytosis.","date":"2011","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/21883766","citation_count":26,"is_preprint":false},{"pmid":"35837166","id":"PMC_35837166","title":"Abrogation of ARF6 in promoting erastin-induced ferroptosis and mitigating capecitabine resistance in gastric cancer cells.","date":"2022","source":"Journal of gastrointestinal oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35837166","citation_count":25,"is_preprint":false},{"pmid":"30674481","id":"PMC_30674481","title":"A crucial role for Arf6 in the response of commissural axons to Slit.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30674481","citation_count":25,"is_preprint":false},{"pmid":"22179837","id":"PMC_22179837","title":"Inhibition of cell migration by PITENINs: the role of ARF6.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22179837","citation_count":25,"is_preprint":false},{"pmid":"22916275","id":"PMC_22916275","title":"ARF6-dependent regulation of P2Y receptor traffic and function in human platelets.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22916275","citation_count":24,"is_preprint":false},{"pmid":"21438025","id":"PMC_21438025","title":"Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells.","date":"2011","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/21438025","citation_count":24,"is_preprint":false},{"pmid":"37928258","id":"PMC_37928258","title":"Platelet-derived extracellular vesicles aggravate septic acute kidney injury via delivering ARF6.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37928258","citation_count":23,"is_preprint":false},{"pmid":"31591185","id":"PMC_31591185","title":"Arf6 regulates RhoB subcellular localization to control cancer cell invasion.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31591185","citation_count":23,"is_preprint":false},{"pmid":"28584192","id":"PMC_28584192","title":"Arf6 and Rab22 mediate T cell conjugate formation by regulating clathrin-independent endosomal membrane trafficking.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28584192","citation_count":23,"is_preprint":false},{"pmid":"19061866","id":"PMC_19061866","title":"ARF6, PI3-kinase and host cell actin cytoskeleton in Toxoplasma gondii cell invasion.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19061866","citation_count":23,"is_preprint":false},{"pmid":"34001163","id":"PMC_34001163","title":"Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.","date":"2021","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/34001163","citation_count":23,"is_preprint":false},{"pmid":"31206670","id":"PMC_31206670","title":"Small GTPase Arf6 regulates diabetes-induced cholesterol accumulation in podocytes.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31206670","citation_count":23,"is_preprint":false},{"pmid":"30404949","id":"PMC_30404949","title":"HGF-induced migration depends on the PI(3,4,5)P3-binding microexon-spliced variant of the Arf6 exchange factor cytohesin-1.","date":"2018","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30404949","citation_count":23,"is_preprint":false},{"pmid":"32077148","id":"PMC_32077148","title":"MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32077148","citation_count":22,"is_preprint":false},{"pmid":"15674428","id":"PMC_15674428","title":"Regulation of G protein-coupled receptor endocytosis by ARF6 GTP-binding proteins.","date":"2004","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/15674428","citation_count":22,"is_preprint":false},{"pmid":"29848659","id":"PMC_29848659","title":"Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6.","date":"2018","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/29848659","citation_count":22,"is_preprint":false},{"pmid":"32119711","id":"PMC_32119711","title":"Angiotensin II promotes podocyte injury by activating Arf6-Erk1/2-Nox4 signaling pathway.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32119711","citation_count":22,"is_preprint":false},{"pmid":"34423792","id":"PMC_34423792","title":"Arf6 exacerbates allergic asthma through cell-to-cell transmission of ASC inflammasomes.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34423792","citation_count":21,"is_preprint":false},{"pmid":"30220571","id":"PMC_30220571","title":"RAB-35 and ARF-6 GTPases Mediate Engulfment and Clearance Following Linker Cell-Type Death.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30220571","citation_count":21,"is_preprint":false},{"pmid":"25450674","id":"PMC_25450674","title":"Cytohesin 2/ARF6 regulates preadipocyte migration through the activation of ERK1/2.","date":"2014","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25450674","citation_count":21,"is_preprint":false},{"pmid":"32580737","id":"PMC_32580737","title":"High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32580737","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48725,"output_tokens":15282,"usd":0.187702,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":27908,"output_tokens":5971,"usd":0.144407,"stage2_stop_reason":"end_turn"},"total_usd":0.332109,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"ARF6 localizes to the endosomal/plasma membrane system (not the Golgi) and does not affect COP1 or γ-adaptin assembly on Golgi membranes. GTP hydrolysis-defective ARF6 localizes to the plasma membrane and induces extensive plasma membrane invaginations with depletion of endosomes; GTP-binding-defective ARF6 localizes exclusively to endosomal structures and causes accumulation of coated endocytic structures.\",\n      \"method\": \"Transient transfection of epitope-tagged ARF6 wild-type and GTPase mutants; immuno-electron microscopy; immunofluorescence\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization by immuno-EM with multiple mutants, replicated across the field as foundational work\",\n      \"pmids\": [\"7896867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ARF6 activates phosphatidylinositol 4-phosphate 5-kinase (PIP5K) to generate PIP2 at the plasma membrane and on tubular endosomal structures. PIP2 turnover controlled by the ARF6 GTP/GDP cycle is critical for membrane recycling through the ARF6 plasma membrane-endosomal pathway; constitutively active ARF6-Q67L traps PM proteins (β1-integrin, plakoglobin, MHCI) in PIP2-positive, actin-coated vacuoles unable to recycle.\",\n      \"method\": \"GFP-PH domain reporter for PIP2 localization; expression of ARF6 mutants and EFA6 exchange factor; fluorescence microscopy\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (PIP2 reporter, mutants, exchange factor overexpression), replicated by subsequent studies\",\n      \"pmids\": [\"11535619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ARF6 associates with phospholipase D1 and PKCα upon Fcγ RI immune-complex aggregation; PLD1 lies upstream of all Fcγ RI-mediated PKC activity (PKCδ, ε, ζ translocation requires PLD1, not PKCα activity per se). ARF6 and PKCα form a complex with PLD1 to couple Fcγ RI to PLD1 activation.\",\n      \"method\": \"Co-immunoprecipitation; antisense oligonucleotide knockdown of PLD1; butan-1-ol phosphatidic acid assay; PKC translocation assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and functional knockdown in same study, single lab\",\n      \"pmids\": [\"11516649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ARF6 redistributes to the cleavage furrow during telophase; ARF6-GTP levels transiently increase as cells progress through cytokinesis (measured by pull-down assay). Constitutively active ARF6 localizes to the plasma membrane at the cleavage furrow; dominant negative ARF6 remains cytoplasmic.\",\n      \"method\": \"Endogenous ARF6 immunofluorescence during mitosis; novel ARF6-GTP pull-down assay; expression of GTPase mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment plus biochemical GTP-loading assay, single lab\",\n      \"pmids\": [\"12016212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ARF6 inactivation and acquisition of PI3P are required for convergence of non-clathrin endosomes with EEA1-positive early endosomes. Constitutively active ARF6-Q67L causes MHCI and Tac to accumulate in enlarged PIP2-enriched vacuoles and blocks their fusion with clathrin-cargo-containing endosomes and subsequent degradation, without affecting clathrin-cargo trafficking.\",\n      \"method\": \"Expression of ARF6 mutants; PI3-kinase inhibitor (wortmannin/LY294002); immunofluorescence; live-cell imaging\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (mutant) and pharmacological perturbation with defined cargo readout, single lab\",\n      \"pmids\": [\"12589044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ARF6 regulates axonal elongation and branching through downstream activation of PI(4)P 5-kinase α. Catalytically inactive ARNO or dominant-negative ARF6 enhances axonal extension/branching; this effect is abrogated by constitutively active ARF6. PI(4)P 5-kinase α acts downstream of ARF6 in this pathway. ARF6 inactivation depletes Mena from growth cone leading edges.\",\n      \"method\": \"Expression of ARNO and ARF6 dominant mutants in cultured rat hippocampal neurons; genetic epistasis by co-expression; immunofluorescence for Mena\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis experiment with multiple mutants plus downstream effector rescue, single lab\",\n      \"pmids\": [\"14565977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ARF6 regulates PIP2 formation at the phagocytic cup and activates PIP5K during β1-integrin-mediated bacterial (Yersinia) uptake. ARF6 defective for nucleotide binding reduces PIP2 around bound bacteria and impairs uptake. Overproduction of ARF6 or PIP5K can bypass the Rac1-GTP requirement for bacterial entry.\",\n      \"method\": \"Membrane-targeted PIP2 phosphatase expression; ARF6 dominant-negative mutant; PIP5K overexpression; Rac1 inactivation by YopE; bacterial invasion assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple mutants plus functional phagocytosis readout, single lab\",\n      \"pmids\": [\"12925676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"An initial ARF6-dependent decrease in Rac1-GTP is necessary for epithelial cell-cell dissociation during cell scattering; this is followed by coordinated increases in both ARF6 and Rac1 activation during cell migration.\",\n      \"method\": \"Active GTPase pull-down assays for endogenous ARF6-GTP and Rac1-GTP during sequential stages of HGF/scatter factor-induced MDCK cell scattering\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical pull-down of endogenous active GTPases at defined cellular stages, single lab\",\n      \"pmids\": [\"12609992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"ACAP1 and ACAP2 are ARF6-specific GTPase-activating proteins (GAPs) that function in the cell periphery. In vitro, ACAP1 and ACAP2 have phosphoinositide-dependent GAP activity preferring ARF6 over ARF1 and ARF5. In cells, overexpression of ACAP1/2 blocks ARF6-dependent membrane protrusions; ACAP1/2 are recruited to peripheral tubular membranes where ARF6 activates for membrane recycling.\",\n      \"method\": \"In vitro GAP assay with purified proteins; ARF6-GTP competition; dominant mutant cell biology; immunofluorescence co-localization\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro GAP assay with substrate specificity plus cell-based functional readout, replicated across multiple subsequent studies\",\n      \"pmids\": [\"11062263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ARF6 localizes to invadopodia of breast cancer cells; siRNA-mediated suppression of ARF6 blocks invadopodia formation, localized matrix degradation, and Matrigel transmigration but not cell adhesion. Both GTP hydrolysis-defective (Q67L) and GTP-binding-defective (T27N) ARF6 mutants block invasion, demonstrating that continuous ARF6 GTPase cycling is required.\",\n      \"method\": \"siRNA knockdown; expression of GTPase mutants; invasion assays (Matrigel transmigration, matrix degradation); immunofluorescence\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA KD plus dominant mutant analysis with specific phenotypic readouts, replicated by independent labs\",\n      \"pmids\": [\"15087504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ARF6 is required for completion of cytokinesis. siRNA depletion of ARF6 disrupts the final stages of cytokinesis. Ku70, a DNA-binding protein, is identified as a new ARF6-interacting protein that forms a complex with ARF6 preferentially during mitosis.\",\n      \"method\": \"siRNA knockdown; co-immunoprecipitation; immunofluorescence during cell division\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with specific cytokinesis phenotype plus Co-IP for Ku70 interaction, single lab\",\n      \"pmids\": [\"16181626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ARF6 N-terminal α-helix is co-translationally myristoylated; both the helix and myristate affect nucleotide exchange, membrane association, and interaction with effector proteins.\",\n      \"method\": \"In vitro myristoylation; preparation and biochemical characterization of myristoylated Arf6\",\n      \"journal\": \"Methods in enzymology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical characterization, single lab, no mutagenesis validation in cells\",\n      \"pmids\": [\"16413267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"V-ATPase a2-isoform on early endosomes interacts with ARNO in an intra-endosomal acidification-dependent manner; ARF6 interacts with the c-subunit of V-ATPase. Disruption of ARNO–V-ATPase interaction reversibly inhibits endocytosis and blocks protein trafficking from early to late endosomal compartments.\",\n      \"method\": \"Co-immunoprecipitation; pharmacological inhibition of endosomal acidification (bafilomycin); dominant-negative constructs; endocytosis assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP plus pharmacological and genetic perturbation with functional endocytic readout, published in high-impact journal\",\n      \"pmids\": [\"16415858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BRAG2 (GEP100/Arf-GEP100) is a GEF that activates ARF6 in vivo. siRNA depletion of BRAG2 causes accumulation of β1-integrin on the cell surface and enhanced cell attachment/spreading on fibronectin. Conversely, siRNA depletion of ARF6 causes intracellular accumulation of β1-integrin and reduced adhesion, demonstrating that ARF6 regulates both endocytosis and recycling of β1-integrins.\",\n      \"method\": \"siRNA knockdown of BRAG2 and ARF6; β1-integrin surface and intracellular localization by immunofluorescence and flow cytometry; cell adhesion assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA of both GEF and GTPase with reciprocal cargo phenotypes, clear mechanistic dissection\",\n      \"pmids\": [\"16461286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ARF6 and EFA6A regulate dendritic spine development and maintenance. Active ARF6 promotes spine formation from filopodia; EFA6A promotes spine formation in an ARF6 activation-dependent manner. siRNA knockdown of ARF6 or EFA6A decreases spine formation and reduces filopodia-to-spine conversion. ARF6 and EFA6A protect mature spines from inactivity-induced destabilization.\",\n      \"method\": \"siRNA knockdown; expression of dominant mutants; live-cell imaging; morphometric analysis of spine/filopodia ratio\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD plus dominant mutants plus live imaging, single lab\",\n      \"pmids\": [\"16672654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A kinase-deficient TrkCT1 receptor binds scaffold protein tamalin in a ligand (NT3)-dependent manner; this complex activates ARF6 which in turn activates Rac1. NT3 triggers ARF6 membrane translocation, causing membrane ruffling and cellular protrusions. This identifies NT3 as an upstream regulator of ARF6.\",\n      \"method\": \"Co-immunoprecipitation; ARF6 membrane translocation imaging; dominant-negative mutants; Rac1 GTP pull-down\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional readout of ARF6 and Rac1 activation downstream of receptor, single lab\",\n      \"pmids\": [\"16636148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ACAP4 is a novel ARF6-specific GAP with phosphatidylinositol 4,5-bisphosphate-dependent GAP activity. ACAP4 colocalizes with ARF6 at membrane ruffles upon EGF stimulation. Depletion of ACAP4 by siRNA or inhibition of ARF6 GTP hydrolysis suppresses ARF6-dependent cell migration in wound healing assays.\",\n      \"method\": \"Proteomic identification; in vitro GAP activity assay with PIP2 dependence; siRNA knockdown; co-localization; wound-healing migration assay\",\n      \"journal\": \"Molecular & cellular proteomics : MCP\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro GAP assay plus cell-based siRNA knockdown with migration phenotype, multiple methods in single study\",\n      \"pmids\": [\"16737952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ARF6 activity is regulated during FcγR-mediated phagocytosis. ARF6 activation is restricted to the leading edge of the phagocytic cup. A PI3-kinase-dependent signal transition controls the sequential activation of ARF6 (early, cup leading edge) and ARF1 (delayed, over phagosome). PI3-K inhibition causes persistent ARF6 activation and minimal ARF1 activation.\",\n      \"method\": \"FRET stoichiometric microscopy of CFP/YFP-ARF chimeras and GTP-ARF binding domain; PI3-kinase pharmacological inhibition; phagocytosis assay\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative FRET-based GTPase activation imaging in living cells with spatial-temporal resolution, multiple orthogonal controls\",\n      \"pmids\": [\"16669702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dominant active ARF6 selectively activates PLD2 (not PLD1) in vivo. Dominant negative ARF6 selectively inhibits PLD2. ARF6 activates PLD2 in a cholesterol-dependent membrane microdomain. Co-localization of ARF6 and PLD isoforms was demonstrated at the cell periphery.\",\n      \"method\": \"Co-expression of ARF6 mutants with PLD1/PLD2 in HeLa cells; cell fractionation; methyl-β-cyclodextrin cholesterol depletion; PLD activity assay\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional cell-based assay with multiple mutants plus cholesterol depletion, single lab\",\n      \"pmids\": [\"15759270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSHR (thyrotropin receptor) recycling relies on an hScrib-βPIX-GIT1-ARF6 pathway. ARF6 is activated during TSH stimulation of thyroid cells and is required for TSHR recycling. hScrib directly binds TSHR and associates with a βPIX-GIT1 complex; GIT1 (an ARF6 GAP) and ARF6 are both required for receptor recycling.\",\n      \"method\": \"Dominant-negative constructs; siRNA knockdown; TSHR recycling assay; ARF6 activation assay; co-immunoprecipitation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA plus dominant-negative with functional GPCR trafficking readout, pathway placed by multiple genetic perturbations, single lab\",\n      \"pmids\": [\"15775968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ARF6 regulates angiotensin II type 1 receptor (AT1R) endocytosis by controlling recruitment of AP-2 and clathrin. ARF6-GDP binds β2-adaptin directly; ARF6-GTP preferentially binds clathrin heavy chain. ARF6 depletion prevents agonist-dependent recruitment of β2-adaptin and clathrin to activated AT1R and impairs β-arrestin 2 clustering.\",\n      \"method\": \"In vitro binding assays; co-immunoprecipitation; GFP-tagged adaptors; siRNA knockdown; AT1R endocytosis assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro direct binding assays plus cell-based functional validation, single lab\",\n      \"pmids\": [\"17719203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ARF6 activation downstream of Gαq: Gαq forms molecular complexes preferentially with activated ARNO and ARF6. Direct binding between purified Gαq and ARNO was demonstrated. Gαq-dependent TPβ receptor stimulation activates ARF6, leading to PIP2 production and TPβ receptor internalization.\",\n      \"method\": \"Co-immunoprecipitation; purified protein binding assay; ARF6 activation assay; PIP2 production assay; receptor internalization assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding with purified proteins plus cell-based functional assays, single lab\",\n      \"pmids\": [\"16650966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GULP (CED-6) is a positive regulator of ARF6. GULP binds GDP-bound ARF6 directly via its PTB domain, associates with the ARF6-GAP ACAP1, reverses ACAP1-mediated decrease in ARF6-GTP, and forms a tripartite GULP-ACAP1-ARF6-GDP complex that sequesters ACAP1, thereby increasing cellular ARF6-GTP levels.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins; direct pulldown; siRNA knockdown; ARF6-GTP pull-down; cell migration assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple binding assays (Co-IP, direct pulldown, tripartite complex) plus functional readout, single lab\",\n      \"pmids\": [\"17398097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ARF6-dependent tubulogenesis requires activation of ERK and subsequent Rac1 activation via ERK-induced upregulation of the urokinase plasminogen activator receptor (uPAR). ARF6 activation is necessary and sufficient to initiate tubule extension in 3D MDCK cultures and regulates subcellular distribution of Rac1 to tubule extensions.\",\n      \"method\": \"Inducible expression of ARF6 mutants; 3D cell culture (Matrigel); ERK activation assays; Rac1 distribution imaging\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible mutant expression plus mechanistic downstream pathway dissection in 3D culture model, single lab\",\n      \"pmids\": [\"17363898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Fbx8, an F-box protein containing a Sec7 domain, mediates ubiquitination of ARF6. This ubiquitination is not linked to immediate proteasomal degradation but renders ARF6 functionally inactive; Fbx8 knockdown causes ARF6 hyperactivation. Both F-box and Sec7 domains of Fbx8 are required to suppress ARF6 activity and tumor cell invasiveness.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; siRNA knockdown; ARF6 activity assay; invasion assay; domain deletion mutants\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assay plus siRNA KD plus domain mutagenesis, single lab\",\n      \"pmids\": [\"18094045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CaSR (calcium-sensing receptor) stimulation induces plasma membrane ruffling via a β-arrestin-1/ARNO/ARF6/ELMO cascade. β-arrestin-1 co-immunoprecipitates with CaSR and ARNO; agonist treatment triggers co-translocation of CaSR, β-arrestin-1 and ARNO to membrane protrusions. ARF6 and ELMO are required for CaSR-dependent cytoskeletal reorganization.\",\n      \"method\": \"Co-immunoprecipitation; dominant-negative constructs; siRNA knockdown; immunofluorescence co-localization at membrane ruffles\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus siRNA/dominant-negative with morphological readout, single lab\",\n      \"pmids\": [\"17623778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ARF6 is required for dendritic cell podosome formation and migration. Expression of either Q67L (GTP-locked) or T44N (GDP-locked) ARF6 mutants strongly inhibits F-actin-rich podosome formation and impairs immature DC migration toward CCL3. LPS-stimulated macropinocytosis is suppressed by Q67L ARF6.\",\n      \"method\": \"Retroviral expression of ARF6 mutants in primary murine dendritic cells; F-actin podosome quantification; migration assay toward chemokines\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both GDP- and GTP-locked mutants in primary cells with specific phenotypic readouts, single lab\",\n      \"pmids\": [\"18286566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ARF6 GTP/GDP cycle regulates the release of protease-loaded plasma membrane-derived microvesicles from tumor cells. Mechanistically: ARF6-GTP activates phospholipase D, which recruits ERK to the plasma membrane; ERK phosphorylates and activates MLCK; MLCK-mediated MLC phosphorylation is required for microvesicle release. PKC-mediated MLC phosphorylation (downstream of ARF6 inhibition) blocks shedding.\",\n      \"method\": \"ARF6 mutant expression; PLD inhibition; ERK inhibition; MLCK inhibition; MLC phosphorylation assay; microvesicle quantification\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — linear pathway established by multiple inhibitors and mutants with quantitative vesicle shedding readout, replicated in the field\",\n      \"pmids\": [\"19896381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EGFR activates ARF6 through the GEF GEP100 in breast cancer cells to promote invasion and metastasis via the EGFR-GEP100-ARF6-AMAP1 pathway. GEP100 directly binds ligand-activated EGFR. Both ARF6 and AMAP1 must be highly overexpressed and EGFR must be ligand-activated for full invasion pathway activation.\",\n      \"method\": \"Co-immunoprecipitation of GEP100 with EGFR; siRNA knockdowns; ARF6 activity assay; Matrigel invasion assay\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus multiple siRNA knockdowns with invasion readout, single lab\",\n      \"pmids\": [\"19416474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EphA2, upon ligand activation by ephrin-A, suppresses ARF6 activity through a Nck1-Git1 signaling pathway. Ligand-activated EphA2 via phospho-Tyr594 binds Nck1 SH2 domain; Nck1 SH3 domain binds Git1 synaptic localizing domain; Git1 then suppresses ARF6. This suppression promotes cell compaction and polarization, enhancing E-cadherin-based cell-cell contacts.\",\n      \"method\": \"ARF6 activity assay; co-immunoprecipitation; phospho-tyrosine mutant EphA2; domain-specific mutants; cell compaction/polarity assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mutant dissection plus ARF6 activity assay with morphological phenotype, single lab\",\n      \"pmids\": [\"19193766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TBC1D24 binds ARF6 (co-immunoprecipitation). TBC1D24 overexpression increases neurite length and arborization; FIME disease mutations (D147H, A509V) significantly revert this phenotype, implicating the ARF6-dependent pathway in brain hyperexcitability.\",\n      \"method\": \"Co-immunoprecipitation; TBC1D24 overexpression and disease mutant expression; neurite morphometry in neurons\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single Co-IP plus functional overexpression assay, mechanistic link to ARF6 pathway established but signaling detail not fully resolved\",\n      \"pmids\": [\"20727515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Activated H-Ras induces methuosis via downstream activation of Rac1 combined with reciprocal inactivation of ARF6. Rac1 activation by H-Ras(G12V) decreases ARF6-GTP; this is mediated by Rac1 stimulation of the ARF6-GAP GIT1. Constitutively active Rac1 interacts with GIT1 by co-immunoprecipitation; shRNA ablation of GIT1 prevents ARF6 inactivation and vacuolization.\",\n      \"method\": \"ARF6-GTP and Rac1-GTP pull-down assays; shRNA knockdown of GIT1; Rac1 inhibitor EHT 1864; co-immunoprecipitation; vacuolization scoring\",\n      \"journal\": \"Molecular cancer research : MCR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic and pharmacological perturbations with biochemical and cellular readouts, single lab\",\n      \"pmids\": [\"20713492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GEP100/Brag2 mediates Sema3E-induced ARF6 activation in endothelial cells downstream of Plexin-D1. Upon Sema3E activation, Plexin-D1 recruits PI4P5-kinase; its product PI(4,5)P2 binds the PH domain of GEP100, enhancing its GEF activity toward ARF6, leading to disassembly of integrin-mediated focal adhesions.\",\n      \"method\": \"Co-immunoprecipitation of Plexin-D1 with PIP5K; PH domain PIP2-binding assay; ARF6 activity assay; focal adhesion disassembly imaging; dominant-negative GEP100\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical PH domain binding assay plus ARF6 activity and functional focal adhesion readout, single lab\",\n      \"pmids\": [\"21795701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"VEGFR2 recruits GEP100 to activate ARF6, and the GEP100-ARF6-AMAP1-cortactin pathway is essential for VEGF-induced angiogenesis activities (cell migration, tube formation, permeability enhancement, VE-cadherin endocytosis).\",\n      \"method\": \"Co-immunoprecipitation; siRNA knockdowns; ARF6 activity assay; tube formation and migration assays; VE-cadherin endocytosis assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus multiple siRNA knockdowns with multiple functional readouts, single lab\",\n      \"pmids\": [\"21858086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARF6 negatively regulates Rab35 activation by using EPI64B as an effector. EPI64B is a Rab35-GAP that functions as an ARF6 effector. Constitutively active ARF6 reduces Rab35 loading into the endocytic pathway at clathrin-coated pits, causing endocytic recycling and cytokinesis defects identical to those of inactivated Rab35.\",\n      \"method\": \"Expression of constitutively active ARF6-Q67L; identification of EPI64B as ARF6 effector; Rab35-GTP levels; endocytic recycling assay; cytokinesis defect scoring\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — identification of effector linking ARF6 to Rab35 regulation plus functional cytokinesis and recycling readouts, mechanistically clear epistasis\",\n      \"pmids\": [\"22226746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARF6-GTP associates with clathrin-coated pits (CCPs) at the plasma membrane in an AP-2-dependent mechanism. In CCPs, ARF6-GTP mediates recruitment of JIP3 and JIP4 effectors after auxilin recruitment. ARF6 does not contribute to receptor-mediated clathrin-dependent endocytosis but instead ARF6-JIP interaction on endocytic vesicles is required for fast microtubule-dependent recycling of the transferrin receptor.\",\n      \"method\": \"TIRF microscopy of GFP-ARF6; AP-2 mutant analysis; ARF6-JIP interaction assays; transferrin receptor recycling assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — TIRF microscopy with multiple genetic controls, clear separation of activation from effector function, multiple orthogonal assays\",\n      \"pmids\": [\"21439824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"IL-1β signals through a NF-κB-independent MYD88-ARNO-ARF6 pathway to disrupt endothelial barrier function. ARNO binds directly to MYD88; this interaction activates ARF6, which disrupts endothelial cell-cell junctions. The ARF6-GEF inhibitor SecinH3 enhances vascular stability and improves outcomes in animal models of inflammatory arthritis and acute inflammation.\",\n      \"method\": \"Direct binding assay (MYD88-ARNO); ARF6 activation assay; dominant-negative constructs; SecinH3 pharmacological inhibition; in vitro permeability assay; in vivo inflammatory models\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein-protein binding plus genetic and pharmacological perturbation plus in vivo validation, published in Nature\",\n      \"pmids\": [\"23143332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rab35 suppresses ARF6 activity to maintain cadherins at the cell surface and inhibit cell migration. Rab35 knockdown de-represses ARF6, leading to increased β1-integrin and EGF receptor recycling and decreased E-cadherin at the surface, promoting an EMT-like state.\",\n      \"method\": \"siRNA knockdown of Rab35; ARF6 activity assay; β1-integrin and cadherin surface quantification; migration assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with biochemical ARF6 activity measurement and cargo trafficking readout, single lab\",\n      \"pmids\": [\"23264734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARF6 directs rapid axonal transport of α9β1 integrins in ARF6-positive vesicles. ARF6 inactivation (ACAP1 expression) increases β1 integrin recycling to the neuronal surface and increases anterograde axonal transport; ARF6 activation (ARNO or EFA6 expression) increases retrograde integrin transport and internalization. ARF6 inactivation increases integrin-mediated axon outgrowth.\",\n      \"method\": \"Live-cell imaging of integrin-GFP vesicles in DRG axons and PC12 cells; ACAP1, ARNO, EFA6 overexpression; integrin surface quantification; neurite outgrowth assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell imaging of transport plus multiple GEF/GAP manipulations with functional axon growth readout, single lab\",\n      \"pmids\": [\"22836268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"AGAP3 is a component of the NMDA receptor complex and regulates NMDA receptor-mediated Ras/ERK and ARF6 signaling pathways during chemically induced LTP. AGAP3 knockdown occludes AMPA receptor trafficking during LTP, establishing AGAP3 as a link between NMDA receptor activation and ARF6-dependent AMPA receptor trafficking.\",\n      \"method\": \"Co-immunoprecipitation with NMDA receptor complex; siRNA knockdown; ARF6 activity assay; AMPA receptor trafficking assay during chemically-induced LTP in rat neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus siRNA with functional synaptic plasticity readout, single lab\",\n      \"pmids\": [\"23904596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARF6 and its effector PLD2 control syntenin exosome biogenesis by regulating budding of intraluminal vesicles (ILVs) into multivesicular bodies (MVBs). ARF6 also controls EGF receptor degradation but does not affect HIV-1 budding, excluding a general effect on ESCRT.\",\n      \"method\": \"siRNA knockdown of ARF6 and PLD2; electron microscopy of MVBs and ILVs; exosome quantification; EGFR degradation assay; HIV-1 budding assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown with EM-based ILV quantification plus multiple cargo controls, published in Nature Communications\",\n      \"pmids\": [\"24637612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ARF6 together with JIP3 and JIP4 effectors regulates MT1-MMP exocytosis for cancer cell invasion. JIPs are recruited by WASH on MT1-MMP endosomes and recruit dynein-dynactin and kinesin-1. Plasma membrane ARF6 interacts with endosomal JIPs to coordinate dynein-dynactin and kinesin-1 in a tug-of-war that drives MT1-MMP endosome tubulation and exocytosis. ARF6 or JIP3/4 silencing mispositiones MT1-MMP endosomes and reduces exocytosis and invasion.\",\n      \"method\": \"siRNA silencing; co-immunoprecipitation; live-cell imaging of MT1-MMP endosomes; MT1-MMP exocytosis assay; Matrigel invasion assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA plus Co-IP plus live-cell endosome imaging with exocytosis and invasion readouts, multiple orthogonal approaches\",\n      \"pmids\": [\"26504170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Endothelial-specific deletion of ARF6 abolishes HGF-stimulated β1-integrin recycling and suppresses tumor neoangiogenesis and growth. GEFs GEP100, EFA6B, EFA6D, and Grp1 regulate HGF-stimulated β1-integrin recycling; pharmacological inhibition of the ARF6 GEF Grp1 suppresses tumor vascularization.\",\n      \"method\": \"Conditional endothelial-specific Arf6 knockout mice; β1-integrin recycling assay; tumor implantation model; Grp1 inhibitor pharmacology\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO in primary endothelial cells with in vivo tumor angiogenesis readout plus pharmacological validation\",\n      \"pmids\": [\"26239146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arf6 controls retromer trafficking via a phosphoinositide-based mechanism. Arf6 KO MEFs accumulate free cholesterol in late endosomes/lysosomes due to mistrafficking of NPC2, a cargo of CI-M6PR. This results from a selective increase in endosomal PI4P that perturbs retromer-mediated retrograde transport of CI-M6PR via SNX6 (a PI4P effector). Reducing PI4P in KO MEFs rescues retromer tubulation and cholesterol distribution.\",\n      \"method\": \"Inducible Arf6 knockout MEFs; PI4P immunofluorescence and quantification; retromer tubulation imaging; NPC2 trafficking assay; cholesterol staining; PI4P manipulation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible KO with multiple mechanistic readouts (PI4P, retromer, NPC2, cholesterol) and rescue experiment\",\n      \"pmids\": [\"27336679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arf6 controls platelet spreading and clot retraction via αIIbβ3 integrin trafficking. Arf6 KO platelets show reduced fibrinogen (Fg) uptake, deficient FITC-Fg internalization, enhanced spreading on Fg, and faster clot retraction, without changes in resting/activated αIIbβ3 levels, MLC phosphorylation, or Rac1/RhoA activation.\",\n      \"method\": \"Platelet-specific Arf6 conditional KO mice; biotinylated/FITC-Fg uptake in vivo and ex vivo; flow cytometry; immunofluorescence of Rab4/Rab11 vesicles; clot retraction assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO mouse model with multiple complementary functional assays and mechanistic controls\",\n      \"pmids\": [\"26738539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LPA activates ARF6 via G-protein-coupled LPA receptors through GTP-Gα12 binding to EFA6 in renal cancer cells, promoting mesenchymal invasion. This is distinct from the GEP100-mediated activation seen in breast cancer cells.\",\n      \"method\": \"ARF6 activity assay; LPA stimulation; Gα12 dominant-negative; EFA6 co-immunoprecipitation; invasion assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical ARF6 activation assay plus Co-IP of pathway components plus functional invasion readout, single lab\",\n      \"pmids\": [\"26854204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The mevalonate pathway enzyme GGT-II and its substrate Rab11b are required for ARF6 trafficking to the plasma membrane for activation by receptor tyrosine kinases. Mutant p53 promotes ARF6 activation by supporting GGT-II and Rab11b. MVP inhibition blocked invasion and metastasis only in cells overexpressing ARF6.\",\n      \"method\": \"GGT-II inhibitor; Rab11b siRNA; ARF6 plasma membrane localization imaging; invasion and metastasis assays; ARF6 activation assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and siRNA perturbation with ARF6 trafficking and activation readouts, single lab\",\n      \"pmids\": [\"27044891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ARF6 controls VEGFR2 trafficking and signaling through two distinct GEFs: ARNO activates ARF6 to promote VEGFR2 internalization; GEP100 activates ARF6 to promote VEGFR2 recycling via coreceptor binding. Both pathways converge to determine VEGFR2 signal output and are targets for diabetic retinopathy intervention.\",\n      \"method\": \"In vitro, cellular, genetic (conditional KO), and pharmacological approaches; VEGFR2 trafficking assay; ARF6 activation assay; ARNO and GEP100 interaction with VEGFR2; in vivo retinopathy models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including conditional KO, biochemistry, pharmacology, and in vivo models in a single study\",\n      \"pmids\": [\"29058688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The Arf6-AMAP1 pathway promotes anterograde trafficking of mitochondria by promoting ILK localization to focal adhesions, thereby blocking RhoT1-TRAK2 (retrograde) association. This is required for avoiding detrimental ROS production during cell invasion.\",\n      \"method\": \"siRNA and dominant-mutant blocking of Arf6-AMAP1 pathway; mitochondria localization imaging; ROS measurement; ILK-focal adhesion immunofluorescence; TRAK1/2 co-immunoprecipitation with RhoT1; invasion assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic perturbations with mechanistic co-IP and functional cellular readouts, single lab\",\n      \"pmids\": [\"29992963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Microexon switching in the ARF6 GEF cytohesin-1 controls Met-dependent cell migration. Diglycine (microexon-skipped) isoform has differential affinity for PI(3,4,5)P3 vs. triglycine isoform (PI(4,5)P2), directing distinct subcellular localizations—triglycine to plasma membrane, diglycine to leading edge—thereby spatially restricting ARF6 activation and downstream HGF/Met-dependent migration.\",\n      \"method\": \"Phosphoinositide-binding assay; subcellular localization imaging; Met receptor co-immunoprecipitation; microexon isoform rescue; cell migration assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical PI-binding assay plus live-cell localization plus functional migration rescue, single lab\",\n      \"pmids\": [\"30404949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ARF6-GTP forms a cytoplasmic shuttle with GRP1 that captures pre-miRNA/Exportin-5 complex following Ran-GTP dissociation after nuclear export, delivering pre-miRNA cargo to nascent tumor microvesicles. ARF6 activation increases pre-miRNA content in TMVs through a process requiring casein kinase 2-mediated phosphorylation of RanGAP1.\",\n      \"method\": \"Co-immunoprecipitation of ARF6-GTP, GRP1, Exportin-5, pre-miRNA; ARF6 activation manipulation; CK2 inhibition/mutation; TMV pre-miRNA quantification\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple Co-IPs plus mechanistic CK2 phosphorylation step plus functional cargo quantification, published in Nature Cell Biology\",\n      \"pmids\": [\"31235936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Arf6 is required for commissural axon midline crossing; Slit-Robo1 signaling activates Arf6 via cytohesins. Arf6 mediates endocytosis and recycling of Robo1 receptor, which maintains receptor stability during Slit stimulation. A positive feedback loop is established: Robo1 endocytosis triggers Arf6-mediated amplification of Slit response.\",\n      \"method\": \"Arf6-knockout mice (commissural axon phenotype); cytohesin dominant-negative; Robo1 endocytosis/recycling assay; ARF6 activation assay; in vivo axon guidance imaging\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout mouse with in vivo axon guidance phenotype plus biochemical endocytosis/recycling assays\",\n      \"pmids\": [\"30674481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ARF6 forms a complex with RhoB; the GCI residues (188-190) of RhoB mediate this interaction. Targeting ARF6 to plasma membrane or mitochondrial membranes promotes co-recruitment of RhoB. ARF6 depletion causes RhoB loss from endosomal membranes and RhoB degradation via an endolysosomal pathway, resulting in defective actin and focal adhesion dynamics.\",\n      \"method\": \"Co-immunoprecipitation; ARF6 targeted to specific membranes; confocal imaging of RhoB localization; ARF6 KD; RhoB degradation assay; focal adhesion imaging\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus targeted ARF6 experiments with RhoB localization and degradation readouts, single lab\",\n      \"pmids\": [\"31591185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Arf6 and macropinocytosis machinery (JIP3, dynein) shape macropinosome formation and inward movement. Arf6 and JIP3 (a microtubule motor scaffold/ARF6 effector) are required for sealing and transport of macropinosomes through the actin-myosin-rich lamellar region along microtubule tracks.\",\n      \"method\": \"siRNA knockdown of Arf6, JIP3, dynein; live-cell imaging of macropinosome formation and transport; microtubule depolymerization\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdowns with live-cell imaging in multiple conditions, single lab\",\n      \"pmids\": [\"30969891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KRAS promotes ARF6 mRNA translation through eIF4A-dependent mechanism involving a G-quadruplex structure in the 5'-UTR of ARF6 mRNA, by inducing TEAD3 and ETV4 to suppress PDCD4. TP53 facilitates ARF6 activation by PDGF via promoting PDGFRβ expression and mevalonate pathway enzymes.\",\n      \"method\": \"Translational reporter for ARF6 5'-UTR; eIF4A inhibitor silvestrol; PDCD4 knockdown; ARF6 activity assay upon PDGF stimulation; KPC mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — translational reporter assay plus eIF4A inhibition plus in vivo KPC model, single lab\",\n      \"pmids\": [\"31399545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"N-myristoylated ARF6 recognizes palmitoylated EGFR via lipid-lipid interaction, recruits the exocyst complex to promote EGFR budding from the Golgi, and facilitates EGFR transport to the plasma membrane in its GTP-bound form. DHHC13 palmitoylates EGFR, which is critical for plasma membrane localization.\",\n      \"method\": \"Co-immunoprecipitation; lipid-lipid interaction assay; EGFR palmitoylation assay (DHHC13 identification); exocyst recruitment assay; plasma membrane EGFR localization; cell-permeable peptide (GKVL-TAT) disrupting this interaction\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus lipid interaction assay plus functional EGFR sorting readout, single lab\",\n      \"pmids\": [\"36224181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ARF6-mediated recruitment of PIP5K1C converts PI(4)P to PI(4,5)P2 on late-stage vesicles near the plasma membrane, driving exocyst recruitment and membrane tethering. Reconstitution of functional octameric human exocyst demonstrated that each subcomplex independently binds PI(4,5)P2 for membrane tethering.\",\n      \"method\": \"Reconstitution of functional octameric exocyst; in vitro membrane tethering assay; PI(4,5)P2 binding assay; ARF6-PIP5K1C membrane recruitment experiment; epithelial cell biology validation\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of exocyst tethering plus biochemical lipid binding plus cell-based validation, multiple orthogonal methods\",\n      \"pmids\": [\"35609603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DDR1 activates ARF6 by recruiting the GEF PSD4 in a collagen-stimulated, DDR1 kinase-dependent manner in hepatocellular carcinoma cells. DDR1 physically interacts with ARF6 (co-immunoprecipitation). DDR1 kinase activity is required for ARF6 activation.\",\n      \"method\": \"Co-immunoprecipitation; kinase-dead DDR1 mutant; ARF6 activity assay; PSD4 recruitment assay; invasion and metastasis assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus kinase mutant plus ARF6 activity assay with metastasis readout, single lab\",\n      \"pmids\": [\"35140331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LRRK2-hyperphosphorylated RABs disrupt autophagosome axonal transport by disrupting coordinated regulation of dynein and kinesin. ARF6 overexpression attenuates transport defects in LRRK2-p.R1441H knockin and PPM1H knockout neurons, acting as a switch for selective activation of dynein or kinesin.\",\n      \"method\": \"iPSC-derived human neurons with LRRK2-p.R1441H knockin; PPM1H knockout; ARF6 overexpression rescue; live-cell imaging of autophagosome transport\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — iPSC-derived neurons with knockin mutation plus ARF6 rescue with live-cell transport imaging, single lab\",\n      \"pmids\": [\"37133994\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARF6 is a small GTPase that cycles between GDP- and GTP-bound states at the plasma membrane and endosomal compartments, where it orchestrates membrane trafficking (clathrin-independent endocytosis and recycling, integrin and receptor recycling, microvesicle shedding, exosome biogenesis, macropinocytosis), actin cytoskeleton remodeling, and signaling by activating downstream effectors including PIP5K (generating PI(4,5)P2), phospholipase D2, the exocyst complex, and JIP3/JIP4 motor scaffold proteins; its GTP/GDP cycle is controlled by a repertoire of GEFs (ARNO/cytohesin-2, GEP100/BRAG2, EFA6, GRP1) and GAPs (ACAP1/2/4, ARAP2, GIT1, EPI64B), and is regulated post-translationally by Fbx8-mediated ubiquitination and upstream by receptor tyrosine kinases (EGFR, VEGFR2, Met, DDR1), GPCRs (LH/CGR, AT1R, CaSR, P2Y), Gαq, and the mevalonate pathway, enabling ARF6 to control diverse processes including cancer invasion and metastasis (via integrin/MT1-MMP recycling, microvesicle release, and PD-L1 dynamics), cytokinesis, dendritic spine formation, axon guidance, vascular stability, and cholesterol homeostasis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARF6 is a small GTPase of the endosomal/plasma membrane system whose GTP/GDP cycle governs clathrin-independent endocytosis, cargo recycling, actin remodeling, and regulated membrane budding, distinct from Golgi-associated ARF function [#0]. A central output of activated ARF6 is the local generation of phosphoinositides: ARF6-GTP recruits and activates PIP5K to produce PI(4,5)P2 at the plasma membrane and on tubular endosomes, and PI(4,5)P2 turnover driven by the GTPase cycle is required for cargo recycling, with constitutively active ARF6 trapping integrins and other surface proteins in PI(4,5)P2-positive, actin-coated vacuoles [#1]; ARF6 inactivation and acquisition of PI3P in turn permit fusion of non-clathrin endosomes with the EEA1 pathway [#4], and loss of ARF6 perturbs endosomal PI4P to disrupt retromer-mediated retrograde transport and cholesterol distribution [#43]. ARF6 also activates phospholipase D2 in cholesterol-dependent microdomains [#18] and recruits the exocyst complex via PIP5K1C-generated PI(4,5)P2 to tether vesicles at the plasma membrane [#56]. Through these activities ARF6 controls receptor and integrin endocytosis/recycling—including β1-integrin handled via the GEF BRAG2/GEP100 [#13] and recycling coordinated by ARF6-GTP binding of clathrin and JIP3/JIP4 motor scaffolds on endocytic vesicles for microtubule-dependent transferrin receptor recycling [#35]. ARF6 drives cancer cell invasion by directing MT1-MMP endosome exocytosis through JIP3/JIP4–dynein/kinesin coordination [#41] and by promoting protease-loaded microvesicle shedding via a PLD–ERK–MLCK cascade [#27], and its release of pre-miRNA-loaded tumor microvesicles requires a GRP1/Exportin-5 shuttle [#50]. Its cycle is set by ARF6-specific GAPs including ACAP1/2 and ACAP4 [#8, #16] and a diverse repertoire of GEFs (ARNO, GEP100, EFA6, GRP1, PSD4) acting downstream of receptors such as EGFR, VEGFR2, Met, DDR1, GPCRs, and Gαq [#28, #47, #57], and is further tuned by Fbx8-mediated ubiquitination that inactivates ARF6 [#24] and by reciprocal antagonism with Rab35 [#34, #37]. Physiologically, endothelial ARF6 supports HGF-stimulated β1-integrin recycling and tumor neoangiogenesis [#42], ARF6 controls platelet integrin trafficking and clot retraction [#44], maintains endothelial barrier integrity downstream of IL-1β/MYD88/ARNO [#36], and is required for cytokinesis [#10, #34], dendritic spine formation [#14], and commissural axon midline crossing via Robo1 recycling [#51].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established that ARF6 acts in the endosomal/plasma membrane system rather than the Golgi, defining its compartment and showing that its GTPase state dictates membrane morphology.\",\n      \"evidence\": \"Immuno-EM and immunofluorescence of epitope-tagged wild-type and GTPase-mutant ARF6\",\n      \"pmids\": [\"7896867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify effectors linking GTP state to membrane remodeling\", \"Cargo-level consequences not yet defined\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified PI(4,5)P2 generation via PIP5K as the central lipid output of the ARF6 cycle controlling recycling, explaining how the GTPase remodels membranes.\",\n      \"evidence\": \"GFP-PH PI(4,5)P2 reporter with ARF6 mutants and EFA6 in cultured cells\",\n      \"pmids\": [\"11535619\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical PIP5K activation kinetics not resolved here\", \"How PI(4,5)P2 turnover is coupled to specific recycling steps unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the GAP arm of the cycle by showing ACAP1/2 are ARF6-specific, PI-dependent GAPs acting peripherally, the first specific ARF6 inactivators.\",\n      \"evidence\": \"In vitro GAP assays with substrate specificity plus cell-based protrusion readout\",\n      \"pmids\": [\"11062263\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatial recruitment cues for ACAPs in vivo not fully defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed ARF6 inactivation and PI3P acquisition are required for non-clathrin endosomes to converge with the canonical EEA1 early-endosome pathway, positioning the cycle within endosome maturation.\",\n      \"evidence\": \"ARF6 mutants plus PI3-kinase inhibitors with defined cargo readouts\",\n      \"pmids\": [\"12589044\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GAP responsible for inactivation step not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved spatiotemporal control of ARF6 in living cells, showing activation restricted to leading edges and switching to ARF1 downstream of a PI3K signal during phagocytosis.\",\n      \"evidence\": \"FRET stoichiometric microscopy of ARF chimeras with PI3K inhibition\",\n      \"pmids\": [\"16669702\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF/GAP identities producing the spatial gradient not pinned down\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected receptor trafficking machinery to ARF6 by identifying ARNO-V-ATPase coupling as an acidification-sensitive control point for endosomal progression.\",\n      \"evidence\": \"Reciprocal Co-IP, bafilomycin, dominant-negatives, endocytosis assays\",\n      \"pmids\": [\"16415858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How acidification state is transduced to GEF activity mechanistically unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated ARF6 controls β1-integrin endocytosis and recycling via the GEF BRAG2/GEP100, linking the cycle to adhesion dynamics.\",\n      \"evidence\": \"siRNA of GEF and GTPase with reciprocal surface/internal integrin phenotypes\",\n      \"pmids\": [\"16461286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of BRAG2 selectivity for ARF6 not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a linear ARF6-GTP→PLD→ERK→MLCK→MLC cascade driving protease-loaded microvesicle shedding, mechanistically tying ARF6 to tumor microvesicle biogenesis.\",\n      \"evidence\": \"ARF6 mutants with PLD, ERK, MLCK inhibition and vesicle quantification\",\n      \"pmids\": [\"19896381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo selection into microvesicles not fully resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Separated ARF6 activation at clathrin-coated pits from its effector role, showing ARF6-JIP recruitment drives microtubule-dependent fast recycling rather than endocytosis itself.\",\n      \"evidence\": \"TIRF microscopy of GFP-ARF6 with AP-2 mutants and recycling assays\",\n      \"pmids\": [\"21439824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How AP-2 selects ARF6-GTP at CCPs mechanistically undefined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed ARF6 in reciprocal antagonism with Rab35 by identifying EPI64B as an ARF6 effector that is a Rab35-GAP, linking the two GTPases in recycling and cytokinesis.\",\n      \"evidence\": \"Constitutively active ARF6, effector identification, Rab35-GTP and cytokinesis readouts\",\n      \"pmids\": [\"22226746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reciprocal Rab35-driven ARF6 suppression mechanism addressed separately\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended ARF6 to vascular physiology by showing IL-1β acts through a MYD88-ARNO-ARF6 axis to disrupt endothelial junctions, validated pharmacologically in vivo.\",\n      \"evidence\": \"Direct MYD88-ARNO binding, SecinH3 inhibition, permeability and in vivo inflammation models\",\n      \"pmids\": [\"23143332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Junctional cargo internalized by ARF6 not enumerated here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined ARF6/PLD2 control of intraluminal vesicle budding into MVBs for syntenin exosome biogenesis, distinct from general ESCRT-dependent budding.\",\n      \"evidence\": \"siRNA of ARF6/PLD2 with EM of ILVs and cargo controls (EGFR, HIV-1)\",\n      \"pmids\": [\"24637612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ARF6/PLD2 lipids drive inward budding topologically unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Explained how ARF6 drives invasion by coordinating JIP3/JIP4 with dynein-dynactin and kinesin-1 in a motor tug-of-war driving MT1-MMP endosome exocytosis.\",\n      \"evidence\": \"siRNA, Co-IP, live-cell endosome imaging, exocytosis and invasion assays\",\n      \"pmids\": [\"26504170\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative balance of motor forces not measured\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated in vivo that endothelial ARF6 is required for HGF-stimulated β1-integrin recycling and tumor neoangiogenesis, with multiple GEFs and Grp1 as a druggable node.\",\n      \"evidence\": \"Endothelial-specific Arf6 conditional KO mice, recycling assays, tumor models, Grp1 inhibitor\",\n      \"pmids\": [\"26239146\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of individual GEFs in vivo not separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Linked ARF6 to lipid/cholesterol homeostasis by showing Arf6 loss elevates endosomal PI4P, disrupting SNX6/retromer retrograde transport of CI-M6PR and NPC2.\",\n      \"evidence\": \"Inducible Arf6 KO MEFs with PI4P, retromer tubulation, NPC2 and cholesterol readouts plus rescue\",\n      \"pmids\": [\"27336679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ARF6 limits endosomal PI4P levels biochemically unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established physiological roles in hemostasis, showing platelet Arf6 controls αIIbβ3-mediated fibrinogen uptake, spreading and clot retraction.\",\n      \"evidence\": \"Platelet-specific Arf6 KO mice with fibrinogen uptake, spreading and clot retraction assays\",\n      \"pmids\": [\"26738539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEF/GAP controlling platelet ARF6 not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed two GEFs route ARF6 to opposite VEGFR2 fates—ARNO to internalization, GEP100 to recycling—integrating signal output, with relevance to retinopathy.\",\n      \"evidence\": \"Conditional KO, biochemistry, pharmacology, and in vivo retinopathy models\",\n      \"pmids\": [\"29058688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GEF choice is biased at a given receptor pool unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a non-trafficking role: an ARF6-GTP/GRP1 shuttle captures pre-miRNA/Exportin-5 for delivery into tumor microvesicles, regulated by CK2 phosphorylation of RanGAP1.\",\n      \"evidence\": \"Co-IPs of ARF6-GTP/GRP1/Exportin-5/pre-miRNA with CK2 perturbation and TMV cargo quantification\",\n      \"pmids\": [\"31235936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cytoplasmic ARF6-GTP intercepts the export complex spatially undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established an in vivo neurodevelopmental role, showing Arf6 mediates Robo1 endocytosis/recycling for commissural axon midline crossing via a Slit-driven positive feedback loop.\",\n      \"evidence\": \"Arf6 KO mice, cytohesin dominant-negatives, Robo1 trafficking and in vivo axon guidance\",\n      \"pmids\": [\"30674481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of feedback amplification not fully dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Reconstituted how ARF6 promotes exocyst-mediated tethering, recruiting PIP5K1C to generate PI(4,5)P2 that engages each exocyst subcomplex for membrane attachment.\",\n      \"evidence\": \"Reconstituted octameric exocyst, in vitro tethering and lipid binding, ARF6-PIP5K1C recruitment, cell validation\",\n      \"pmids\": [\"35609603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ARF6-exocyst contacts vs. lipid-mediated recruitment not fully separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse GEF/GAP repertoire, post-translational modifications, and lipid microenvironments are integrated to specify ARF6 activation at a precise location, time, and cargo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of GEF/GAP selection per stimulus\", \"Structural basis of ARF6 effector switching incompletely defined\", \"In vivo cargo-specific recycling itineraries largely uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 3, 8, 16, 17]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [15, 28, 47, 57]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 18, 34, 56]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 3, 35]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 4, 35, 43]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [35, 41, 50]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [3, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 4, 13, 35, 41]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [35, 38, 47, 55]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [28, 36, 47, 51]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 10, 34]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [9, 27, 41, 42]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [43, 46, 54]}\n    ],\n    \"complexes\": [\"exocyst\"],\n    \"partners\": [\"ARNO\", \"GEP100\", \"EFA6\", \"GRP1\", \"ACAP1\", \"JIP3\", \"JIP4\", \"RhoB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}